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Zusammenfassung 
Peptidyl-Prolyl-cis/trans-Isomerasen (PPIasen) sind Enzyme, die cis/trans-Isomerisierung von 
Peptidyl-Prolyl-Bindungen (Xaa-Pro-Bindungen) katalysieren. Parvulin 14 (Par14) und seine 
Isoform Par17 gehören zu der Familie der Parvuline, einer Untergruppe der PPIasen. Für 
Par14 wurde gezeigt, dass es an DNA bindet. In einer anderen Studie wurde gezeigt, dass 
Par14 Teil des preribosomalen Ribonukleoprotein-Komplexes ist und ein RNA-
Prozessierungsfaktor sei, welcher in der Ribosomenbiogenese involviert ist. Par17 kommt nur 
in Hominidae vor und ist in den Mitochondrien lokalisiert. Um Bindungspartner für Par14/17 
(Peptide oder Proteine) zu finden, wurden Hochdurchsatz-Screening-Verfahren, das Yeast-
two-Hybrid-System (Y2H) und das Phagen-Display (Ph.D.) verwendet. In der Y2H-Studie 
wurde ein target-unrelated-protein (TUP) gefunden. Im Ph.D. Screening gegen PinA von 
Cenarchaeum symbiosum wurde ein Peptid gefunden, das PinA mit niedriger Affinität bindet. 
Mithilfe des Peptids konnte ein vermutliches aktives Zentrum der PPIase PinA zugeordnet 
werden. Ebenfalls wurden  eine 7 und 12-mer Peptidbibliothek gegen Par17 entwickelt. Die 
Konsensus-Sequenz XHSXVHØ wurde aus beiden Bibliotheken angereichert, wobei X eine 
beliebige Aminosäure und Ø eine hydrophobe Aminosäure darstellt. Die Bindung dieses 
Motivs an Par14/17 wurde über Phagen-ELISA und NMR-Spektroskopie untersucht, wobei 
gezeigt werden konnte, dass dieses Motiv an die Par14/17 PPIase Domäne bindet. Mithilfe 
dieser Peptide wurde das putative aktive Zentrum von Par14/17 in den NMR-Strukturen 
zugeordnet. Desweiteren können besagte Peptide zukünftig dazu verwendet werden, 
potentielle Bindungspartner von Par14/17 zu finden. 
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Summary 
Peptidyl prolyl cis/trans isomerases (PPIases) are the enzymes that increase the rate of 
isomerization of the peptide bond N-terminal to the proline substrate. Parvulin14 (Par14) and 
its isoform Par17 belong to the Parvulin family which is the third family of PPIases. Par14 
was shown to bind the DNA. Par14 was also proposed to be a part from the pre-ribosomal 
ribonucleoprotien complexes and an RNA processing factor that is involved in ribosome 
biogenesis. The longer isoform Par17 was shown to be expressed only in the Hominidae, and 
is targeted to the mitochondria. In order to find binding partners for Par14/17 (peptides or 
proteins), we applied the high through-put screening methods, the yeast two-hybrid (Y2H) 
and the phage display (Ph.D.). In our Y2H study we show a target-unrelated protein that may 
confuse a number of Y2H results. In our Ph.D. screening against PinA of Cenarchaeum 
symbiosum we selected a peptide that binds PinA with low affinity; however we used this 
peptide to map PinA putative PPIase active site, and to show a flexible region of PinA. The 
flexibility of this region is probably a general feature of the peptidyl prolyl cis/trans 
isomerization. Furthermore, we panned 7 and 12-mer peptide libraries against Par17. One 
consensus sequence was enriched from both libraries, XHSXVHØ, where X can be any amino 
acid and Ø is a hydrophobic amino acid. We demonstrate the binding of this motif to Par14/17 
with phage ELISA and NMR spectroscopy where we could show that this motif is binding to 
the PPIase domain of Par14/17. Moreover, using these peptides we map the PPIase active site 
of Par14/17. Our peptides can be used to design peptides to study the PPIase activity of 
Par14/17, and to elucidate the motif that Par14/17 recognizes in vivo.  
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1. Introduction  
1.1 Peptidyl Prolyl cis/trans Isomerases (PPIases) 
The peptidyl prolyl cis/trans isomerases (PPIases EC number 5.2.1.8) are enzymes that are 
capable to increase the rate of isomerization of the peptide bond N-terminal to the proline 
substrate (figure 1.1). In the literature they are often called rotamases or rotomases (Fischer, 
1994) due to the conformational change they catalyzed. There are 3 known families of 
proteins with a PPIase activity. These families are FKBPs, cyclophillins, and parvulins. 
 
 
Figure1.1. The PPIases increase the rate of isomerization of the prolyl peptide bond 
Isomerization of a peptide bond N-terminal to the proline (shown in red here) by a PPIase. 
Substrate that is shown here is phosphorylated Ser-Pro-Ala (Shaw, 2002). 
 
The first family of PPIases are FK506 binding proteins (FKBPs) or Macrophilins. 
Macrophilins were reported to bind the immunosuppressive drug, FK506 and have a PPIase 
activity (Siekierka et al., 1989; Fischer, 1994).  
The second family are the cyclophilins that bind the drug Cyclosporin A which was the drug 
of choice for auto-immune diseases before FK506. Cyclophilins bind cyclosporine A (a cyclic 
peptide) and possess PPIase activity that is crucial for protein folding during proteins 
biosynthesis (Schönbrunner et al., 1991). The PPIase activity of cyclophilin is strongly 
inhibited in the presence of low level of cyclosporin A indicating that they bind each other 
(Fischer et al., 1989; Takahashi et al., 1989).  
The third family of PPIases are the parvulins conserved from bacteria to human. This family 
has been confirmed after the description of the E. coli parvulin, Par10 (Uchida et al., 1999). 
Par10 is localized to Escherichia coli cytosol, and it is the smallest parvulin protein ever 
described with 93 amino acid residues and a calculated molecular weight of 10101 Da. Par10 
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contains only a PPIase domain with neither N nor C-terminal extensions (figure 1.2). The 
third family of the PPIases is called Parvulin because it is small (a Latin word means very 
small) compared to the other well-established PPIase families (Rahfeld et al., 1994). The 
members of parvulins family are resistant against the inhibitors of cyclophilins and FKBPs. 
The most important member of Parvulins family is human hPin1 (hPar18, figure 1.2) which 
has been identified in a yeast two-hybrid screen, as a protein interacting with the essential 
NIMA (in Aspergillus nidualns) protein kinase and suppresses its mitosis-promoting activity 
(Lu et al., 1996). The same study reported that the depletion of Pin1/Ess1 (Ess1 is a yeast 
parvulin) from the yeast or Hela cells induces mitotic arrest, whereas Hela cells over-
expressing Pin1 arrest in G2 phase of the cell cycle. The crystal structure of hPin1 revealed 
that the residues Lys63, Arg68 and Arg69 form a basic cluster at the entrance of the active 
site in the PPIase domain of hPin1. This basic cluster prefers an acidic group N-terminal to 
proline in the substrate protein (Ranganathan et al., 1997).  Therefore, it was suggested that 
Pin1 is a phosphorylation dependent PPIase, that specifically recognizes phosphorylated 
Ser/Thr residues preceding proline in mitotic phosphoproteins (Ranganathan et al., 1997).  
In another study, it was demonstrated that hPin1 binds to the phosphorylated Ser/Thr (Yaffe et 
al., 1997). In this report, a two-step mechanism for hPin1 mitotic regulation was proposed. 
The first step is the phosphorylation of Thr/Ser-Pro by mitotic kinases that creates a binding 
site for hPin1. In the second step, hPin1 would bind and catalyze conformational changes by 
isomerization of the peptide bond N-terminal to the proline in phosphoproteins such as NIMA 
kinase or Cdc25. Thus, the function of these phosphoproteins will be changed in terms of their 
degradation or their interactions with other proteins. Therefore, the isomerization catalyzed by 
hPin1 would affect the entire downstream mitotic pathway (Yaffe et al., 1997).  
Recently, the NMR solution structure of Pin A from the mesosphilic archaeon, Cenarchaeum 
symbiosum (C.symbiosum) was solved (Jaremko et al., 2011). This mesophilic archaeon is 
closely related to the other nonthermophilic crenarchaeotes, and is able to thrive at low 
temperatures (8-18oC). It inhabits cold water in a symbiotic relationship with the sponge 
Axinella mexicana (Preston et al., 1996). In contrast to hPin1, PinA of C.symbiosum consists 
of 92 amino acid residues with neither N nor C-terminal terminal domains (Jaremko et al 
2011). Little is known about PinA of C.symbiosum except that it folds into ß α3 ß α ß2 like all 
other parvulins. Furthermore, it has a relatively large Proline binding cleft, which might be 
some sort of acclimatization to the cold habitat (Jaremko et al., 2011).  
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The second important member of parvulins family is parvulin14 (figure 1.2). Par14 was 
identified in a human lung cDNA library. It has a molecular mass of 13.676 KDa, and hence 
named Par14 (Uchida et al., 1999). From the northern blot experiments, the gene of Par14 
was identified in human heart, placenta, liver, kidney, and Pancreas. Par14 has 34.5% and 
34% sequence similarities to Par10 and hPin1 respectively (Uchida et al., 1999). Contrary to 
human Pin1, Par14 exhibits a preference for an arginine residue N-terminal to the Proline and 
has a PPIase activity 1000 times less than that of cyclophilins and FKBPs (Uchida et al., 
1999). The finding of Par14 was confirmed by another study (Rulten et al., 1999). Despite its 
ubiquitous distribution in latter report, they concluded that it is mainly localized to the 
mitochondrial matrix where they have proposed its function. They have also assayed Par14 
PPIase activity with the peptide Suc-Ala-Xaa-Pro-Phe-pNA, where Xaa can be Ala, Glu, Leu 
or Phe. They described recombinant Par14 with no PPIase activity. Weak PPIase activity of 
Par14 was only assayed in the case of a positively charged residue preceding Proline (Uchida 
et al., 1999; Zoldák et al., 2009). 
An extended isoform (25 amino acids N-terminal) of Par14 was identified and named Par17 
(Mueller et al., 2006). The Par14 reading frame contains an additional start codon which lies 
75 nucleotide upstream of the start codon that initiates Par14 translation. This leads to 
translation of a longer isoform (figure 1.2). Par17 is expressed in all human cells examined at 
that study (Mueller et al., 2006). It is not expressed in rodent, bovine and non-mammals. In a 
follow-up study, it was reported that Par17 is imported to the mitochondrial matrix where the 
authors proposed its function in great apes after evolution (Kessler et al., 2007).  
 
 
Figure1.2. Modular structures of parvulin proteins (Mueller and Bayer, 2008)  
Par10 from E. coli with neither N nor C-terminus, hPin1 with its N-terminal WW domain, 
Par14 with the N-terminal basic domain, and Par17 with the 25 amino acids N-terminal 
extension to Par14 basic domain.  
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Although the N-terminal domain of Par14 does not exhibit a sequence similarity to the WW 
domain of hPin1, it attracted much attention. The N-terminal domain of Par14 was reported to 
be a prerequisite for Par14-DNA high affinity binding (Surmacz et al., 2002). In the latter 
study, it was shown that there is structural and sequence homology of Par14 to the 
HMGB/HMGN proteins. Par14 ability to bind the DNA and its structural and sequence 
homology to HMG proteins led the authors to propose a similar function of Par14 to the 
function of HMG proteins (Surmacz et al., 2002). Furthermore, the N-terminal of Par14 was 
also demonstrated to be phosphorylated by a casein kinase at Ser19 in vitro and in vivo 
(Reimer et al., 2003). The same study reported that Ser19 phosphorylation is responsible for 
the localization of Par14 to the nucleus. They have also reported that the dephosphorylated 
Par14 binds the DNA with higher affinity than the phosphorylated form, as the 
phosphorylation may masks the DNA binding surface at the N-terminal of Par14 (Reimer et 
al., 2003). Moreover, it was shown that the amino acids residues from 36-41 of Par14 are 
required for its binding to the pre-ribosomal ribonucleoprotein complexes (pre-rRNP), 
provided that the amino terminal residues (1-35) is included (Fujiyama-Nakamura et al., 
2009). In the latter report, Par14-GST fusion protein was found to be associated with the pre- 
pre-rRNP compexes. These complexes contain ribosomal proteins and transacting factors 
involved in ribosome biogenesis. In that experiment Par14 could also pulldown non-
ribosomal proteins that are expected to participate in microtubule assembly or nucleologenesis 
like tubulin, and fibronectin. Moreover, it was shown by knockdown of Par14 mRNA in 
HEK293 cells, that Par14 is required for normal cell growth (Fujiyama-Nakamura et al., 
2009). 
The NMR solution structure of Par14 was solved by two independent groups (Sekerina et al., 
2000, Terada et al., 2001). Sekerina and co-workers reported that Par14 folds into a Beta 
strand, 3 alpha helices, Beta strand, alpha helix, 2 Beta stands (β, α3, β, α, β2, Figure1.3.A). 
They concluded that a positively charged amino acid N-terminal to the Proline will be 
preferred for the isomerization due to the negative surface potential of Par14. This conclusion 
is consistent with the report by (Uchida et al., 1999) in which a substrate (Ala-Xaa-Pro-Phe-
NH-Np) specificity study was conducted, where aa can be any amino acid. The highest 
specificity constant measured was with an Arginine residue just before the Proline. The same 
result was obtained by Zoldák and co-workers (Zoldák et al., 2009). 
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Terada and co-workers described the solution structure of Par14 (figure 1.3.B) as β 4 and α3. 
Moreover, NMR titration (HSQC) was performed with the peptide Suc-Ala-Leu-Pro-Phe-
pNA. The residues Val91, Met90 and Phe94 showed large chemical shift changes. These 
residues form a hydrophobic core on the molecular surface of Par14. Based on their structural 
alignment, these 3 residues are conserved in Par10 and two of them in hPin1 (Met90 and 
Phe94). Therefore, it was suggested that these are the residues that directly interact with the 
substrate Proline (Terada et al., 2001). 
 
Figure1.3. NMR solution structure of parvulin14 
(A) It folds in β, α3, β, α, β2, (PDB code 1EQ3, Sekerina et al., 2000). (B) It folds in β 4 and 
α3 (PDB code 1FJD, Terada et al., 2001). 
 
Chaperone-like activity was reported for PPIases (Behrens et al., 2001), for instance, SurA is 
a periplasmic PPIase of E. coli and composed of an N-terminal region followed by two 
successive parvulin domains (only the second parvulin domain with a PPIase activity) and a 
C-terminal tail.  SurA was demonstrated to act as a chaperone, its chaperone activity lies in its 
N-terminal region coupled to the C-terminal tail. Both coupled domains (N and C-termini) 
could prevent citrate synthase aggregation better than the full-length SurA. It was also shown 
that SurA N-terminal region coupled to the C-terminal tail is required for SurA outer 
membrane proteins recognition. Therefore, it was concluded that both parvulin domains of 
SurA are dispensable for its chaperone-like activity (Behrens et al., 2001). Another example 
is FKpA, also an E. coli PPIase. It was reported that in the presence of FKpA, the in vitro 
yield of a soluble and functional anti-fluorescein antibody single-chain Fv (scFv) fragment 
was increased without the PPIase activity of FKpA, as the Proline was inaccessible to the 
FKpA (Ramm and Plückthun 2000). The in vivo, FkpA was found to possess a beneficial 
effect on the expression of scFv displayed as fusion to gIII protein of filamentous phage when 
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they were co-expressed in E. coli from the same phagemid. FKpA also increased the 
expression of scFv not containing cis proline (Bothmann and Plückthun, 2000).  
 
1.2. Using the yeast two-hybrid (Y2H) system to find interacting proteins of Par14/17 
The yeast two-hybrid is a powerful genetic assay to study protein-protein interactions (Chien 
et al., 1991; Fields and Song, 1989). This system has been used in thousands of studies, which 
include everything from mapping the contact domains for individual pairs of proteins to 
identifying the entire protein interaction network, or the interactome for the whole the 
organism (Brent and Finely, 1997; Fields, 2005). The assay is carried out inside the nucleus of 
the yeast Saccharomyces cerevisiae where the two proteins to be tested are expressed as 
hybrid molecules. One is fused to the DNA binding domain (DB) of transcription factors such 
as Gal 4 or lex A and is called the bait or the protein of interest. The other one is fused to the 
transcription activation domain (AD) and is called the prey because it is often a clone among 
millions clones in the cDNA library. If the two proteins interact, the AD is brought to the 
promoter of reporter genes containing a specific binding site for the BD, and therefore the 
reporter genes are subsequently transcribed (figure 1.4). 
 
Figure1.4. The principle of yeast two-hybrid system (Finley, 2008) 
If the bait and the prey proteins bind to each other, the DNA binding domain (BD) and the 
transcription activation domain (AD) came in proximity which leads to the transcription and 
translation of the yeast reporter genes.  
 
In practice, false positives and negatives can arise in the Y2H system (von Mering et al., 
2002; Huang and Bader, 2009). False positives are interactions that are reported by the system 
but biologically irrelevant. False positives are classified into technical and biological false 
positives (Finley, 2007). In the case of technical false positives, the reporter genes are 
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activated without a true interaction between the two-hybrid proteins i.e. there is no physical 
binding between the two-hybrid proteins. For instance, when the prey protein binds the 
promoter or the promoter-associated proteins (Finley, 2007). Another possibility to produce a 
technical false positive result, when the AD fusion protein is “sticky” and would interact with 
most proteins, or it interacts with the DNA-binding domain. The other type of false positive is 
biologic false positives. This type occurs when both proteins bind each other only in the yeast 
system, but this is does not happen actually, or in the cell circumstances both proteins do not 
meet each other since each one in a different cellular compartment or with a different 
expression pattern (Finley, 2007). 
 
1.3. Metallothionein 2A (MT2A) as a clone detected many times in yeast two hybrid 
screenings  
Metallothioneins (MTs) are ubiquitous, intracellular, and low molecular weight proteins with 
high cysteine content and metal binding capacity (Sutherland and Stillman, 2011).They had 
been studied for more than five decades since their discovery in 1957 in equine renal tissue 
(Margoshes and Vallee, 1957). The functions of metallothionein families are subject of 
speculation and remain to be challenging. It is thought that they are involved in metal storage, 
detoxification, control of metabolism and other various cellular processes (Karin, 1985). 
Previously, it was shown that there is an increase in the mRNA of MT2 in neurodegenerative 
diseases such as Alzheimer disease (Duguid et al., 1989). Moreover, metallothionein 2A 
seems to be the main isoform associated with cell proliferation in cancer cells (Jin et al., 
2002; Rao et al., 2003; Kim et al., 2011).  
 
In a number of yeast two-hybrid screens using Gal4-based system, MT2A was identified as an 
interaction partner of protein kinase Cµ within prostate cancer cell lines (Rao et al., 2003), as 
an interacting protein of human sex hormone-binding globulin (Pope and Lee, 2005), as an 
interaction partner of hepatitis B protein (Bai et al., 2005), and as a binding partner of 
transthyretin (Gonçalves et al., 2008).  
 
When we screened two cDNA libraries from different tissues using Par17 (Mueller et al., 
2006) as a bait we detected MT2A several times in several screenings as a false positive. 
MT2A has been reported by other researchers (Bai et al., 2005; Pope and Lee, 2005) as a true 
positive though they neither complete the experiment by co-transforming pACT2-MT2A 
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construct with the empty pGBKT7 vector in the yeast cell, nor they confirm the interaction by 
performing a follow-up experiment. Furthermore, MT2A was described as a false positive in 
Y2H in the report by Bosch-Comas and others (Bosch-Comas et al., 2006), and the study by 
Wang and others (Wang et al., 2008). This accumulated occurrence of MT2A clones in the 
Y2H system prompted us to study these MT2A clones in detail.    
 
1.4. Using the Phage Display (Ph.D.) technique to find binding peptides for Par17 in 
attempts to uncover its interaction network  
Bacteriophages are the viruses that infect bacteria. The short name is phage. They are used as 
a vector in DNA technology. Phage display Ph.D. describes a selection technique in which a 
library of peptide is expressed as a fusion to the phage surface proteins or the phage coat 
proteins.  
In the case of M13 bacteriophage libraries, the peptide is expressed fused to the coat minor 
protein pIII in 5 copies. Each copy is expressing or displaying the same peptide. The Ph.D. 
library is applied to the target protein (antibodies, enzymes, cell-surface receptors, etc.), 
followed by several washing steps to remove the unbound phage. The bound phage are then 
eluted, amplified, and subjected to the next round. After 3 to 4 consecutive rounds of selection 
and enrichment, the selected phage are characterized by DNA sequencing and Phage ELISA. 
The application of the peptide library and selecting the binding peptides is called panning, 
which is some sort of affinity selection (figure1.5).   
The phage can take a segment of foreign DNA, and when the phage amplifies in its bacterial 
cell host, the foreign DNA segment can replicate along with it. In the case of expression 
phage vector, the foreign DNA will be expressed as a protein. This protein will be displayed 
fused to the phage coat protein, creating a hybrid protein. The combinatorial phage display 
library is a mixture of phage each one displaying a peptide fused to the phage coat protein. 
The expressed foreign peptides will be exposed to the solvent and often behave as if they are 
free and not attached to the virion surface (As reviewed by Smith and Petrenko, 1997).  
Ph.D. is a powerful method to investigate protein-protein interaction. It was successfully used 
to detect binding partners for a variety of target proteins. For example using Ph.D., Y2H and 
other methods, it was possible to identify the interaction network of the yeast SH3 domain 
(Tong et al., 2002). Furthermore, applying Ph.D. and pulldown, the Groucho proteins, amino 
terminal enhancer of split (AES) was demonstrated to be a binding partner for the high 
mobility group 1, HMGB1 protein (Dintilhac and Bernués, 2002). In the latter study the 
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peptide LPLTPLP was enriched after 3 rounds of panning against HMGB1. The amino acids 
sequence LPLTPLP could be aligned with 100 % homology with the amino acid sequence of 
AES from 140-146. They showed the HMGB1-AES binding a by a pulldown experiment 
(Dintilhac and Bernués, 2002). 
 
 
Figure 1.5. Steps of phage display  
(http://www.hugroup.seas.harvard.edu/group_members/haberer/research/index.php).  
In the phage display panning the target protein is first immobilized (e.g. on a polystyrene 
plate). After washing and blocking steps, the peptide library is applied on the coated blocked 
plate, followed by washing steps and elution of bound phage. 
 
1.5. The bacteriophage M13 used as a vector in phage display Ph.D. technique 
M13 is a filamentous single stranded bacteriophage (eaters of bacteria) of E. coli. The 
Genome of M13 is a single stranded DNA (SS DNA) molecule (~ 6407bp long) coated by 
viral proteins, which are major and minor. In order to construct phage peptide library, the 
peptide is expressed as fusion to the major coat protein or B protein encoded by the gene VIII 
(Smith and Petrenko, 1997, Sidhu, 2000). B protein is present in about 2700 copies (Simons 
et al., 1981), and is forming a spiral around the DNA (figure1.6). The foreign peptide can also 
be displayed as fusion to phage minor coat protein (pIII) encoded by gene III. Protein pIII 
presents in 5 copies for each phage (Lin et al., 1980). 
The first step of M13 replication includes conversion of the single stranded molecule to 
double stranded parental replicative form (RF) molecules. Since this step cannot be blocked 
by chloramphenicol, all the proteins needed for it are suggested to be synthesized by the host 
cell prior to the infection (Pratt and Erdahl, 1968). The second step is the step of progeny 
replicative form synthesis, and starts at 5 min of an infection at 37oC. It is distinguishable by 
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the production of pool of RF double stranded DNA molecules in the infected cells (they reach 
a level of ~ 40 particles per cell after 30 min of an infection at 37oC). This step is blocked by 
chloramphenicol, and by lethal mutation only in M13 gene II, suggesting that cellular proteins 
may contribute to it. The third step starts after 11 minutes of an infection. This is the step 
where the mature single stranded (SS) viral particles start to be released from infective cells, 
and some of them accumulate intra-cellular (Pratt and Erdahl, 1968).  
 
Figure 1.6. M13 structure showing the coat proteins (Marco Antonio Arap, 2005) 
Foreign peptides are displayed on either major coat protein pVIII depicted in dark violet, or 
minor coat protein pIII depicted here in dark green.  
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Objective of this study 
The aim of this project was to find (a) binding partner (s) peptide (s) or protein (s) for 
Parvulin14/17, and the archaeal parvulin Cenarchaeum symbiosum PinA whose NMR 
solution structure had being solved during the course of this study. The Par 14 protein is 
almost conserved from bacteria to human, and is found in any cell tested thus far (Rulten et 
al., 1999; Uchida et al., 1999). A binding protein (s) will give hint about the function of Par14 
using the guilty by association method and the cellular compartment in which Par14 is 
functioning. The binder will help in characterizing Par14 binding sites, and if it contains 
proline substrate it will help to map Par14/17 PPIase active site. With the natural proline 
substrate Par14/17 may exhibit a moderate PPIase activity rather than the very weak activity 
described before (Uchida et al., 1999; Zoldák et al., 2009). Furthermore, this is going to 
reveal which residue should be N-terminal to the Proline substrate. To the best of our 
knowledge, the active site has not been shown with a natural substrate (Sekerina et al., 2000; 
Terada et al., 2001). Moreover, the binding peptides will probably help in prediction of 
Par14/17 interaction network. In order to achieve these goals we have used two approaches. 
The first one was the yeast two-hybrid system (Y2H) where we have screened two cDNA 
libraries, human fatal liver and bone marrow libraries using Par17 as a target protein. The 
second approach was the phage display (Ph.D.). We used Ph.D. technique to screen a 7-mer 
peptide library against the archaeal parvulin, C. symbiosum PinA. In addition, we screened the 
7 and the 12-mer Ph.D. libraries against Par17. The phage display-driven peptides were 
subjected to phage ELISA and NMR spectroscopy. 
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2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals 
Adenine Hemisulfate Dehydrate MB Biomedical, Illkirch, France 
Ammonium peroxodisulphate (APS), Roth, Karlsruhe, Germany  
Ammonium sulphate (NH4)2SO4 Roth, Karlsruhe, Germany 
Bis-Rotiphorese gel 30%, Roth, Karlsruhe, Germany 
Bovine serum albumin for Phage ELISA, Sigma-Aldrich Chemie Gmbh, Munich, Germany   
Bovine serum albumin for other experiments, Roth Karlsruhe, Germany                   
Bromophenol blue, Roth, Karlsruhe, Germany 
Calcium chloride CaCl2 Roth, Karlsruhe, Germany 
Chloropane (phenol-chloroform-isoamyl alcohol, Roth, Karlsruhe, Germany 
Complete supplement mixture –Trp –Leu –His –Ade MB Biomedical, Illkirch, France 
Disodium hydrogen phosphate Na2HPO4 Roth, Karlsruhe, Germany 
Ethylene diaminetetraacetic acid (EDTA), Roth, Karlsruhe, Germany Dimethyl Sulfoxide 
DMSO, Roth, Karlsruhe, Germany 
Ferric citrate, Sigma-Aldrich Chemie Gmbh, Munich, Germany   
Glucose monohydrate, Roth, Karlsruhe, Germany 
Glycerol 86%, Roth, Karlsruhe, Germany  
Glycine, Roth, Karlsruhe, Germany 
Histidine, Serva, Feinbiochemica, Heidelberg, Germany   
Leucine, Roth, Karlsruhe, Germany 
Lithium Acetate, Roth, Karlsruhe, Germany 
Magnesium sulphate MgSo4, Fluka, Germany  
PMSF (phenylmethyl-sulphonyl fluoride), Serva Electrophor GmbH, Heidelberg, Germany 
Potassium dihydrogen phosphate KH2PO4 Roth, Karlsruhe, Germany 
Sodium Acetate, Roth, Karlsruhe, Germany  
Sodium dodecyl sulphate SDS, Roth, Karlsruhe, Germany 
Temed 99%, Roth, Karlsruhe, Germany 
Thiamine chloride (Vitamin B1) Merck, Darmstadt, Germany 
Tris, Roth, Karlsruhe, Germany 
Tryptophan Sigma-Aldrich Chemie GmbH, Steinheim, Germany  
Tween 20, Roth, Karlsruhe, Germany 
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Urea, Roth, Karlsruhe, Germany 
X apha Gal, BIOSYNTH AG, Staad, Switzerland  
Yeast nitrogen base without amino acids, MB Biomedical, Illkirch, France  
β mercaptoethanol, Serva Feinbiochemica, Heidelberg, Germany 
SSFPPLLD, ChemCube Bochum, Germany 
KHSPVHIGGGSNH2, JPT peptide technologies, Berlin, Germany 
 
2.1.2. Reagents of molecular biology  
Herring Sperm DNA, Promega Gmbh, Mannheim, Germany 
NdeI and EcoRI, NEB, Frankfurt, Germany  
Pfu Polymerase, Fermentas, Sankt-leon-Rot, Germany   
T4 DNA ligase Metabion, Martinsried, Germany 
Taq DNA polymerase Metabion, Martinsried, Germany 
 
2.1.3. Complementary DNA libraries and Phage display peptide libraries  
Bone marrow cDNA library, Clontech, Heidelberg, Germany 
Fetal liver cDNA library, Clontech, Heidelberg, Germany 
Ph.D.-12™ phage display peptide library Kit, New England Biolabs, Frankfurt, Germany 
Ph.D.-7™ phage display peptide library Kit New, England Biolabs, Frankfurt, Germany 
 
2.1.4. Plasmid vectors and yeast strains 
AH109 Saccharomyces cerevisiae, Clontech, Heidelberg, Germany 
pCL1 Control Vector, Clontech, Heidelberg, Germany 
pGADT7 cloning vector, Clontech, Heidelberg, Germany 
pGADT7-T Control Vector, Clontech, Heidelberg, Germany 
pGBKT7 cloning vector, Clontech, Heidelberg, Germany  
pGBKT7-53 Control Vector, Clontech, Heidelberg, Germany 
pGBKT7-Lam Control Vector, Clontech, Heidelberg, Germany 
Y187 Saccharomyces cerevisiae, Clontech, Heidelberg, Germany 
 
2.1.5. Media  
M9-Medium 1 L  
6.81 g Na2HPO4, 3g KH2PO4, 1g NaCl, 1 g
 15NH4Cl, ddH2O to the final volume of 1 litter and 
autoclaved. The following were added: MgSO4 to the final concentration of ~ 0.002 M, 2ml 
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from TS2 (50X), freshly prepared Fr (III)-Citrate to the final concentration of 0.01mM, 
glucose to the final concentration of 0.4%, CaCl2 to the final concentration of 0.0001 M, 
vitamin B1 to the final concentration of 0.00005 %., and Kanamycin to the final concentration 
of 40 µg / ml. 
YPD medium and synthetic dropout (SD) medium 
These media were prepared according to the Manufacturer's protocol (Clontech, Yeast 
Protocol Handbook, protocol No. PT3024-1, version No. PR742227). 
LB medium 
A mixture of 10g tryptone, 5 g yeast extract, 10g NaCl, ddH2O to the final volume of 1000.  
The mixture was autoclave at 121oC for 20 minutes.  
 
2.1.6. Antibiotics 
Ampicillin, Roth, Karlsruhe, Germany 
Kanamycin sulphate, Roth, Karlsruhe, Germany 
 
2.1.7. Antibodies  
Anti Gal4 AD, Labgene, NatuTec, Frankfurt, Germany 
Anti-rabbit IgG HRP conjugate from Monkey, GE healthcare, Buckinghamshire, UK 
Anti-mouse HRP conjugate Amersham, Freiburg, Germany 
Anti-Par14 PPIase domain, Eurogenetic, Belgium 
 
2.1.8. The SDS-PAGE 
Separating gel  
12.45 ml for 12% (or 15ml for 15%)  Bis-Rotiphorese gel 30%  
6.6 ml 1.8 M Tris-HCl pH 8.8 separating gel buffer 
300 µl SDS 10% 
300 µl Ammonium peroxodisulphate APS 10 % 
12 µl Temed 99%  
ddH2O to the final volume of 30 ml 
Stacking gel 
1190 µl Bis-Rotiphorese gel 30%  
700 µl 1.25M Tris-HCl pH 6.8 collecting gel buffer  
70 µl from SDS 10% 
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70 µl from APS  
7 µl from Temed 99%  
dd H2O to the final volume of 7 ml.   
 
2.1.9. Buffers and solutions 
2.1.9. A. Buffers for plasmid mini-preparation from E. coli, alkaline extraction 
S1 buffer 
50 mM Tris/HCl (pH 8) 
10 mM EDTA 
100 µg RNAase A/ml   
100µg/ml RNase were dissolved in 10mM NaAc pH 5.2, and warmed for 15 minutes at 
100oC, allowed to cool at room temperature and neutralized by addition of 0.1 volumes 1M 
Tris HCl pH 7.4                 
S3 buffer 
2.6 M KAc/pH 5.2 CH3COOH                                                                      
S2 buffer  
200 mM NaOH, 1% (w/v) SDS 
 
2.1.9. B. Solutions for protein extraction from the yeast  
Cracking buffer stock solution 
48g Urea  
5g SDS  
4 ml from Tris-HCl pH (6.8) 1 M stock solution  
20 μl EDTA 0.5 M stock solution  
40 mg Bromophenol blue  
dd H2O to a final volume of 100 ml 
The protease inhibitor stock solution (7X), was prepared by dissolving one tablet from 
complete Mini, EDTA-free (Roche, Manheim, Germany) in 1.5 ml ddH2O. 
PMSF stock solution  
PMSF 0.1742g was dissolved in 10 ml isopropanol, wrapped in foil and stored at room 
temperature. 
Cracking buffer working solution 
1ml cracking buffer stock solution 
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10 µl β mercaptoethanol 
80 µl from protease inhibitor solution,  
50 µl PMSF stock solution 
 
2.1.9. C. TS2 (50X) for M9 medium  
700 mg ZnSO4-7H2O 
30 mg MnCl2-4H2O 
300 mg H3BO3 
200 mg CoCl2-6H2O 
200 mg NiCl2-6H2O 
10 mg CuCl2-2H2O 
900 mg Na2MoO4 
20 mg Na2SeO3 
1000 ml ddH2O 
 
2.1.10. Protein molecular weight markers  
Magic Mark, Invitrogen, Darmstadt, Germany 
Page ruler, Fermentas, Sankt Leon-Rot, Germany  
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2.1.11 Oligonucleotides used in this study  
Protein Amplified  
protein 
Oligonucleotide 
 
Sequence 5´—3´ 
 
Parvulin 17 
Parvulin 17 full-
length 1-156 aa 
Jo255 Forward 
 
AAA  TTT   GGG  CAT  ATG  CCC 
ATG  GCG  GGG  CTT  CTA  AAG 
621 Reverse CAC ACA GAA TTC ATT ATT TTC 
TTC CTT CGA CCA TAA TAA TAT G 
 
Parvulin 14 
Parvulin 14 
Full-length 
1-131 aa 
487 F GTG TGT GTG CAT ATG CCG CCC 
AAA GGA AAA AGT GG 
621 R CAC ACA GAA TTC ATT ATT  TTC 
TTC CTT CGA CCA TAA TAA TAT G 
 
Parvulin 14           
PPIase 
C-terminal of 
Parvulin 14 
454 F CTC   TCT  CAT  ATG  AAT  GCA 
GTA AAG  GTC  AGA  CAC 
621 R CAC  ACA  GAA TTC ATT ATT TTC 
TTC CTT CGA CCA TAA TAA TAT G 
Gal 4 AD 
fusion protein 
(Clontech) 
Gal4 AD fused 
to library insert 
e.g. MT2A 
LD amplimer F CTA  TTC  GAT  GAT  GAA  GAT 
ACC  CCA  CCA  AAC  CC 
LD amplimer R GTG AAC TTG CGG GGT TTT 
TCA GTA TCT ACG AT 
- 96 
Sequencing 
primer  (NEB) 
Minor coat 
protein (pIII) of 
M13 
- 96 sequencing 
primer  (NEB) 
 
CCC TCA TAG TTA GCG TAA CG 
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2.2 Methods 
2.2.1 Cloning of the baits, Pa14/17 and Par14 PPIase domain used in the yeast two- 
hybrid screens 
2.2.1.1. PCR amplification of Parvulin17 cDNA  
PCR was performed by mixing the following, 5 µl from 10X pfu buffer, 4 µl 2.5mM dNTPs, 
2 µl JO 255 forward primer (10 pmol/ul), 2 µl 621 reverse primer (10pmol/µl), 35.4 µl DNase 
/ RNase free ddH2O, 0.8 µl plasmid DNA and 0.8 µl Pfu polymerase (Fermentas, Germany). 
The thermal cycling profile was as follows: 2 min initial denaturation at 94oC, followed by 35 
cycles of 94oC for 30 sec denaturation, annealing 66oC for 30 Sec, 72oC for 1min extension, 
and a final extension at 72oC for 10 min. Lid temperature was 110oC, block temperature was 
4oC. 
 
2.2.1.2. PCR amplification of Parvulin14 cDNA 
PCR was performed by mixing the following, 5 µl from 10X pfu buffer, 4 µl 2.5mM dNTPs, 
2 µl 487 forward primer (10 pmol/ul), 2 µl 621 reverse primer (10pmol/µl), 35.4 µl 
DNase/RNase free ddH2O, 0.8 µl plasmid DNA and 0.8 µl Pfu polymerase (Fermentas). The 
thermal cycling profiles was as follows: 2 min at 94oC for initial denaturation, followed by 35 
cycles of 94oC for 30 sec for denaturation, annealing at 66oC for 30 Sec, 1 min for extensions 
at 72oC, and a final extension at 72oC for 10 min. Lid temperature was 110oC, block 
temperature was 4oC. 
 
2.2.1.3. PCR amplification of parvulin 14 PPIase 
The PCR was performed by mixing the following in 1.5 microcentrifuge tube, 5 µl from 
(10X) pfu buffer, 4 µl 2.5mM dNTPs, 2 µl  454 forward primer (10 pmol/ul), 2 µl  621R 
(10pmol/ µl), 35 µl DNase/RNase free ddH2O, 1 µl plasmid DNA and 1 µl Pfu polymerase 
(Fermentas). The thermal cycling profiles was as follows: 2 min at 94oC for initial 
denaturation, followed by 35 cycle of 94oC for 30 sec for denaturation, annealing at 60oC for 
30 Sec, 72oC for 1 min for extension, and a final extension at 72oC for 10 min. Lid 
temperature was 110oC, block temperature was 4oC. 
 
2.2.1.4. Cloning of the baits, Pa14/17 and Par14 PPIase in the Gal 4 BD encoding vector, 
pGBKT7 
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Gels containing the PCR products (Par17, Par14, and PPIase of Par14) were excised and 
DNA was extracted using the Hi Yield kit (SLG, Sued-Laborbedarf GmbH, Gauting, 
Germany). The extracted DNA was measured using Nanodrop spectrophotometer at 260 nm 
(ND1000, Peqlab Biotechnologie, Germany), the concentration were as follows: Par17 was ~ 
60ng/µl, Par14 was ~ 40ng/ µl, and PPIase of Par14 was ~ 40ng/µl.  
The PCR products were digested with the restriction enzymes NdeI and EcoRI (NEB, 
Frankfurt, Germany) using the following protocol: 5 µl from NEB buffer4 (10X), Bovine 
serum albumin BSA 1.25 µl, 26 µl from DNA extracted from gel, 1.5 µl EcoRI, 1.5 µl NdeI, 
and 14.75 µl DNase / RNase free ddH2O to the final volume of 50 µl, the 1.5 microcentrifuge 
tube containing the digestion mixture was incubated at 37oC for 2 hrs.  
The digestion products were then purified using the Hi Yield PCR Clean-up (SLG, Sued-
Laborbedarf GmbH, Gauting, Germany). Their DNA concentrations were as follows Par17 ~ 
40ng/µl, Par14 ~10ng/µl and the Par14 PPIase ~ 10ng/µl.  
The pGBKT7 was also digested with the same restriction enzymes NdeI and EcoRI (NEB) by 
mixing the followings: 37.35 µl DNase/RNase free ddH2O, 5 µl NEB buffer 4 (10X), 1.25 
BSA (NEB), 3.4 µl pGBKT7 (500ng/ul), 1.5µl EcoRI, and 1.5µl NdeI. The 1.5 
microcentrifuge tube containing the digestion mixture was incubated at 37oC for 2 hrs. The 
digested vector pGPKT7 was treated with alkaline phosphatase, AP to prevent vector re-
ligation using the following protocol: 1 µl phosphatase (1 U/µl) in 5 µl AP buffer + 50 µl 
pGBKT7 (digestion product), 37oC for 30 min, followed by inactivation of AP at 65oC for 5 
min. The digested vector pGBKT7 was run in agarose and extracted from the gel using and 
vector DNA purified the kit Hi Yield (SLG, Sued-Laborbedarf GmbH, Gauting, Germany). 
The DNA concentration of vector digestion product was ~ 250 ng/µl. The digestion products 
of each of Par17, Par14 and Par14 PPIase were cloned in-frame (ligated) to the vector 
pGBKT7 by mixing in 1.5 microcentrifuge tube following: 5 µl from each of Par17, Pa14 or 
Par14 PPIase, 2.5 µl pGBKT7, 0.8 µl ATP (25mM) to the final concentration of 1mM, 2 µl 
ligase buffer T4, 1 µl T4 DNA Ligase, and 8.7 DNase/ RNase free H2O to the final volume of 
20 µl the ligation mixtures were then incubated at 16oC overnight.  
To verify that the cloning was successful, each of the ligation products of pGBKT7-Par17, 
pGBKT7-Par14 and pGBKT7-Par14 PPIase were digested with the restriction enzymes 
EcoRI and NdeI by mixing the following in 1.5 microcentrifuge tube: 2µl (buffer4) NEB, 1 µl 
BSA, 8 µl ligation product, 1 µl EcoRI, 1 µl NdeI, and 7 µl ddH2O, the tube was incubated at 
37oC for 2 hrs. The digestion products were then run on 1.5% agarose gel stained with 
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ethidium bromide. The digestion products of pGBKT7-Par17, pGBKT7-Par14 and pGBKT7-
Par14 PPIase gave bands at their predicted molecular weights of 471bp, 396bp, and 291bp 
respectively. All constructs were then verified by DNA sequencing (GATC Konstanz, 
Germany). For bacterial transformation, 5 µl were taken from the ligation product. 
 
2.2.2. Bacterial chemical transformation  
An aliquot of home-made chemical competent cells in 1.5 microcentrifuge tube (70-100 µl) 
was removed from -80oC and thawed on ice. Ten µl (10-100ng of DNA) of plasmid were 
added to the aliquot, which was pipetted up and down to mix well. The 1.5 microcentrifuge 
tube was placed immediately on ice for at least 10 minutes. The cells were then heat shocked 
on a thermoblock for 45-50 sec at exactly 42oC, and re-placed immediately on ice for 2 min. 
To allow outgrowth, 900 µl of room temperature Soc (preferably) or LB medium were added 
followed by incubation at 37oC for at least 1 hr with shaking at ~ 300 rpm. The culture was 
centrifuged at 14000 rpm for 20-30 sec, 600-700 µl from the supernatant were discarded, and 
the rest was plated on an LB agar containing the appropriate antibiotic. To amplify the 
plasmid, O/N culture was prepared by inoculating LB medium containing the appropriate 
antibiotic with a bacterial colony. Then the plasmid was extracted from the bacteria using the 
protocol of Birnboim and Doly (1979). 
 
2.2.3. Yeast transformation with Lithium Acetate (LiAc) mediated method.  
The protocol described here was used for the transformation of the yeast strain AH109. It was 
scaled up for library screenings or down for plasmids transformation (Clontech, Yeast 
Protocol Handbook, protocol No. PT3024-1, version No. PR742227). To prepare yeast 
overnight culture (O/N), 1 ml of YPD or SD by medium was inoculated with several colonies 
2-3mm in diameter. For yeast strain that is previously transformed with another autonomously 
replicating plasmid, the appropriate SD medium was used to maintain the plasmid. The 
inoculated 1 ml was vigorously vortexed for 1-2 minutes to disperse any clumps, and 
transferred to a flask containing 50 ml of YPD or the appropriate SD medium. To avoid 
bacterial contamination, Kanamycin was added to all yeast media to the final concentration of 
50µg/ml. The O/N culture was incubated at 30oC for 16-18 hrs at 250 rpm to the stationary 
phase (OD600>1.5), then 300 ml from the YPD medium was diluted with the O/N culture (10-
30 ml), the OD600 was checked, the 300 ml were diluted until the OD600 was brought to 0.2-
0.3. The culture was incubated at 30oC for 3-4 hrs at 230 rpm. After the incubation the OD600 
MATERIALS AND METHODS 
 
21 
 
should be 0.4-0.6, otherwise there was something wrong with the latter culture (expansion 
culture). The culture was removed, distributed into 50 ml falcon tubes and centrifuged at 
1000g for 5 minutes at room temperature (20-21oC).The supernatant was discarded and the 
pellets were re-suspended in sterile TE buffer or distilled water by vigorous vortexing. All cell 
pellets were pooled into one 50 ml falcon tubes, centrifuged as before and the supernatant was 
discarded. The cell pellet was re-suspended in 1.5 ml from sterile 1X TE / 1X LiAc (freshly 
prepared by mixing 750 µl from 2X TE buffer and 750 µl from 2X LiAc buffer). Plasmid 
DNA ~ 0.1 µg  was mixed with 0.1mg of herring testes carrier DNA (Herring Sperm DNA 
Promega, Mannheim, Germany) in a fresh 1.5 ml tube, in the case of simultaneous co-
transformation with two different plasmids, both plasmids were mixed with approximately 
equal molar ratio and then 0.1 mg carrier DNA was added. The competent cells in 1X TE/1X 
LiAc (0.1-0.2 ml) were added to mixture of plasmid (s) and the carrier DNA then mixed well 
by vortexing, 0.6 ml of sterile PEG/LiAc solution is added to each tube and mixed by 
vigorous vortexing for at least 20 sec.  The mixtures were incubated at 30oC for 30 min at 200 
rpm (1.5 ml thermomixer, Eppendorf, Germany), then 70 µl of DMSO were added and mixed 
by gentle inversion. The cells were heat shocked at 42oC for 15 min (in 1.5 ml thermomixer), 
chilled on ice for 1-2 min, and centrifuged at 13200 rpm for 10 sec at room temperature, the 
supernatant was removed. The cells were re- suspended in 1X TE buffer, and plated in the 
appropriate SD medium, the plates were incubated at 30oC for a week. 
 
2.2.4. Extraction of proteins from yeast 
The protocol described here was employed to extract proteins from yeast Urea SDS method, 
Clontech, Yeast Protocol Handbook, version No PR742227. SD medium (5ml) was 
inoculated with colonies of the yeast strain AH109. The AH109 strain was independently 
transformed with pGBKT7-Par17, pGBKT7-Par14 and pGBKT7-Par14 PPIase constructs. 
The cultures were vigorously vortexed to disperse any cell clumps. An YPD culture (10ml) 
was also inoculated with untransformed yeast strain AH109 as negative control. The cultures 
were incubated at 30oC with shaking 250-300 rpm overnight.  
In next day the O/N cultures were vigorously vortexed to disperse clumps and diluted in 50 
ml YPD medium (total culture volume will be 55ml) for each clone to be assayed. The diluted 
cultures were incubated (4-8hrs) until the OD600
 reached 0.4-0.6. 
The OD600 of 1 ml was multiplied by the total volume of the culture (e.g. if the OD600 of 1 ml 
is 0.5, the total OD600 units will be 0.5X 55= 27.5 units).    
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On ice, the cultures were quickly distributed in 50 ml falcon tubes and centrifuged at 1000g 
for 5 minutes at 4oC. The supernatants were discarded, the pellets were re-suspended in ice-
cold distilled H2O, and the pellets were recovered by re-centrifugation as before. The 
supernatants were removed; the pellets were quickly snap-frozen with liquid nitrogen and 
stored at -80oC until needed.  
The freshly prepared complete cracking buffer was prepared as described in Clontech Yeast 
Protocol Handbook and pre-warmed to 60oC. Each cell pellet was re-suspended (to thaw 
them) in the complete cracking buffer, 100 µl per 7.5 OD600 units were added to the cell 
pellet, e.g. if the total OD600 units was 27.5, we added 366.7 µl. When the cell pellets were not 
thawed immediately by the pre-warmed cracking buffer, they were placed at 60oC for no 
longer than 2 minutes to avoid proteolysis. Because PMSF in the cracking buffer degrades 
quickly, additional aliquots of 100 X PMSF stock solutions were added to the samples after 
15 min of starting the protocol, and approximately every 7 min thereafter until the samples 
were placed on ice or they were stored at - 80oC. 
The cell pellet suspensions were each transferred to 1.5 microcentrifuge tube containing 80 µl 
of glass beads (425–600 μm)  per 7.5 OD600
 units of the cells (the volume of the glass beads 
could be estimated using a graduated 1.5 micro-centrifuge tube). The samples were heated at 
70oC for 10 minutes, vortexed vigorously for 1 minute, and then cell were centrifuged at 
14000 rpm for 5 minutes. The supernatant from each tube was transferred to a fresh 1.5 micro 
centrifuge tube and placed on ice. The tubes containing pellets were placed in a boiling water 
path for 3-5 minutes, vortexed vigorously for 1 minute, and centrifuged at 14 000 rpm for 5 
min at 4oC. The supernatant from each tube transferred to its corresponding first supernatant 
placed on ice. The samples were snap-frozen and stored at -08oC.   
 
2.2.5. Verification of Gal4 BD fusion proteins by SDS and western blot analysis  
Proteins were extracted from the transformant yeast cells AH109 using Urea/SDS method 
(Yeast protocol Handbook, Clontech) prior to analysis by SDS-PAGE, transferred to a 
Nitrocellulose acetate membrane and probed with antibody against Par14 PPIase domain 
(Kessler et al., 2007) as a primary antibody for overnight and anti-rabbit as a secondary 
antibody for 2 hrs at room temperature (Amersham Bioscience, UK). The immunoreactive 
proteins were visualized by ECL (Amersham Bioscience). 
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2.2.6. Test for autonomous activity  
To test the auto-activation of the bait constructs, the yeast strain AH109 was transformed 
simultaneously with plasmid pGBKT7 cloned with Par17, Par14, and Par14 PPIase DNA 
sequences as baits vector and empty library vector pGADT7. The bait vector expresses Gal4 
BD fused to Par 14, Par 17 and Par14 PPIase proteins, and confers the Tryptophan (Trp). The 
empty library vector pGADT7 expresses Gal4 AD and confer Leucine. 
The transformant yeast cells with the bait constructs (Par14.pGBKT7, Par17.pGBKT7 and 
PPIase.pBGKT7) as well as the positive and negative controls were suspended in 500 µl YPD 
medium, 50 µl were taken for measurement of the optical density OD600 which later was 
adjusted to 5. Then 200 µl were pipetted in 96 well sterile plate from each. The suspensions 
were then 10-fold serially diluted until the OD 0.00005. One drop from each well was 
transferred to SD plates selecting for the desired transformants cells, (SD –Trp –Leu) and SD 
plate selecting for the reporter genes activation (SD –Trp –Leu –His –Ade). The plates were 
incubated at 30o C for 6-7 days. 
 
2.2.7. Screenings of the cDNA libraries  
Two cDNA libraries (Clontech, Heidelberg, Germany) were screened, a human fetal liver and 
a bone marrow library. Both of the libraries were constructed in the vector pACT2.  
 
2.2.7.1 Fetal liver cDNA library screening using Par17 as bait  
The fetal liver library was screened with Par17 as bait, using yeast transformation protocol 
(Matchmaker™ GAL4 Two-Hybrid System 3 & Libraries User Manual, Protocol No. 
PT3247-1 version no. PR742219). 
 
2.7.1.1. A. Sequential yeast transformation 
The yeast strain AH109 was transformed with bait pGPKT7-Par17, using protocol of LiAc 
mediated transformation. The transformant yeast cells were grown on the medium SD –Trp 
for 1 week at 30oC. The selected transformant cells were then sequentially transformed with 
the fetal liver library. The transformant yeast cells were grown in the medium SD –Trp –Leu– 
Ade –His (high stringency selective medium). After 1 week of incubation at 30o C, only 4 
colonies were observed as positive colonies in the high stringency medium. The four colonies 
were re-streaked in the medium SD –Trp –Leu –Ade –His containing X alpha Gal (Biosynth, 
Staad, Switzerland) to test for the activation of the reporter gene MEL I (production of alpha 
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galactosidase). After incubation for 5 days at 30o C, all of them grew and turned blue. For 
calculation of transformation efficiency:- 
     = cfu/µg DNA     (Eq.1) 
• 19 cfu in the plate SD –Leu –Trp. 
• Total suspension volume was 10ml.  
• The amount of the library plasmid = 90 µg 
• Volume plate in the dilution plate = 100 µl. 
• Dilution factor 1:100, 0.01  
The transformation efficiency according to equation number 1       
 
Calculate of the number of the clones screened 
cfu/ µg  µg of the library plasmid used = No. of the clones screened                              (Eq.2) 
The number of the clones screened according to equation number 2 will be as follows:- 
2.1  103 cfu /µg  90 µg = 1.9  105 clones screened.                
To calculation of transformation efficiency for the library plasmid pACT2 
• 2 cfu in the plate SD/–Leu. 
• Total suspension volume or transformation mixture is 10ml. 
• Volume plate in the dilution plate = 100 µl. 
• Dilution factor 1:100, 0.01. 
• The amount of the library plasmid = 90 µg.  
For the plasmid pACT2 the transformation efficiency according to equation number 1 will be 
as follows:-    
 
2.7.1.1. B. Simultaneous co-transformation  
In the second screen simultaneous co-transformation was performed. In this screen the bait 
plasmid construct, pGBKT7-Par17 and the human fetal liver library plasmid pACT2 were 
introduced simultaneously in the yeast strain AH109. The transformation mixture was then 
plated in SD –Trp –Leu– Ade– His. After incubation at 30oC for 1 week, more than 100 
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colonies were observed in SD –Trp –Leu –Ade –His. To calculate of the transformation 
efficiency                              
• The amount of the library transformed was 80 µg.  
• The transformation mixture or total suspension volume was 10ml. 
• 15 cfu were observed in the medium SD –Trp – Leu.  
• The dilution factor was 1:100. 
• The volume plated is 100 µl 
• Herring Sperm DNA 2mg (Promega Gmbh, Mannheim, Germany). The Herring sperm 
DNA was sheared by repeated passages through a hypodermic needle to reduce the viscosity 
of the solution, and then denatured by boiling for 20 min at 100oC prior to its chilling on ice. 
The transformation efficiency according to equation number 1 will be as follows:- 
 
The number of clones screened according to equation number 2 will be as follows:- 
 
To calculate the transformation efficiency of the bait plasmid pGBKT7-Par17  
• 430 cfu were observed in the medium SD –Trp  
• Dilution factor was 1:100.  
• The transformation mixture or total suspension volume was 10ml.  
• The volume plated is 100 µl. 
• The amount of the bait plasmid, pGBKT7-Par17 is 88 µg 
According to equation number 1, the transformation efficiency of the bait plasmid will be as 
follows:- 
 
According to equation number 1, the transformation efficiency of the library plasmid will be 
as follows:- 
• 49 cfu were observed in the medium SD – Leu 
• Dilution factor was 1:100.  
• The transformation mixture or total suspension volume was 10ml.  
• The volume plated was 100 µl 
• The amount of the library plasmid, pACT2 is 80 µg. the transformation efficiency of the 
library plasmid will be as follows:- 
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2.2.7.2. Screening of the human bone marrow cDNA library by yeast mating 
The Bone Marrow cDNA library which was pre-transformed in the yeast strain Y187, MAT 
alpha. It was screened by yeast mating with the yeast strain AH109, MATa. The yeast strain 
AH109 was pre-transformed with the bait constructs pGBKT7-Par17. Diploids were selected 
in the medium SD –Trp –Leu– Ade –His. The yeast mating was done according to 
manufacturer´s protocol (Matchmaker™ Gold, Yeast Two-Hybrid System, User Manual, 
protocol No. PT4084-1, version No. PR033493). In brief, the O/N culture of AH109 was 
prepared by inoculating a fresh colony in 50 µl SD –Trp containing Kanamycin (50µg/ml), 
and incubated at 30oC at 260 rpm for ~18 hrs until the OD600 reached 1.201. The O/N culture 
was centrifuged at 1000g for 5 min at room temperature. The supernatant was discarded, and 
the cells were re-suspended in 4 ml of SD –Trp. The cell number was 1.3X108 cell/ml 
(counted using a Hemocytometer). The mating mixture was prepared by mixing 1 ml from the 
cDNA bone marrow library and 4 ml of SD –Trp containing AH109. Then 45 ml of 2X 
YPDA medium (containing kanamycin) were added to the mixture. The mixture was 
incubated at 30oC for ~ 20 hours at 40 rpm. After 20 hrs, one drop of the mating mixture was 
examined under the microscope (40X), zygotes were present. Thereafter, the mating was 
stopped, the mixture was centrifuged at 1000 g for 10 min, and the supernatant was discarded. 
The pellet was suspended in 50 ml of 0.5X YPDA medium that were used to rinse the 2L 
mating flask twice. The pellet was recovered by centrifugation at 1000g for 10 min at room 
temperature, the supernatant was discarded. The pelleted cells were resuspended in 10 ml of 
0.5X YPDA (containing kanamycin). The total volume of the cell and the medium was 12 ml, 
100 µl were spread in the plate SD –Trp, SD –Leu and SD –Trp –Leu. The rest was plated in 
SD –Trp –Leu –His –Ade. Equation number 3 was used to calculate the number of the clones 
screened. 
cfu/ml of the diploid  Re-suspension Vol. (ml) = The No. of the clones screened         (Eq.3) 
•Re-suspension Vol. (ml) = 12 ml.  
•Plating volume 100 µl  
•Number of the diploid colonies 2, 30, and 369 cfu in SD –Trp –Leu in the dilution 105, 104, 
and 103 respectively.    
•Number of the bait colonies 1024, too many (cannot be counted), and too many cfu in SD –
Trp in the dilutions 105, 104, 103 respectively.    
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•Number of the library colonies 46, 368, and too many cfu in the SD –Leu in the dilutions 
105, 104, 103 respectively. The number of the clones screened was calculated according to 
equation number 3, and the mating efficiency (Percentage of diploids) was calculated using 
equation number 4.  
                                                                                    (Eq.4)       
 where the limiting partner is the strain of the prey or the bait with the lower viability 
• Viability of the prey or bait = No. of colonies x dilution factor (DF)  10 (cfu in 1ml).  
• 46 colonies of prey library grew on the dilution 105 on SD –Leu  
• 1024 colonies of bait grew on the dilution 105 on SD –Trp  
• 2 colonies of the diploid grew on the dilution 105 on SD –Trp –Leu  
Therefore the viability of the prey library = 46  105  10 = 4.6X107 
Viability of the bait 1024  105  10 = 1.024  109 
Viability of the diploid 2  105  10 = 2  106  
The prey library is the limiting partner. Thus the mating efficiency according to equation 
number 4 will be  
 
2.2.8. Retest of the phenotypes  
In order to verify that all the clones which have grown in the medium SD –Trp –Leu –Ade– 
His maintained the correct phenotype, they were re-streaked in the high stringency medium 
SD –Trp/–Leu/– Ade/–His + X alpha Gal. They were collected in 2 master plates SD –Trp–
Leu– Ade –His + X alpha Gal in a grid fashion.  
 
2.2.9. Plasmid isolation from yeast  
The plasmid isolated from yeast is always contaminated with genomic DNA, and thus, it is 
not pure enough to be digested with restriction enzymes. Besides, it cannot be sequenced, but 
it can be transformed into E. coli (preferably via Electroporation). Moreover, it can also be 
used as a template for PCR amplification. The protocol described here (Byrd and Arnaud, 
2001) was successfully used to extract plasmid from yeast cells. Three ml of SD –Leu was 
inoculated with a well isolated colony from a plate of SD –Trp –Leu. The cultural tube was 
vortexed to disperse the cell clumps and incubated at 30oC until saturation at 300 rpm (the 
culture became milky in appearance in 2-3 days); 1.5 ml from the yeast culture was 
transferred to a microcentrifuge tube and centrifuged at 10000g for 0.5 minutes. The 
MATERIALS AND METHODS 
 
28 
 
supernatant was discarded. The latter step was repeated until the 3 ml culture is pelleted. 
About 0.3 g (or reasonable estimate) of acid-washed glass beads (Glass beads 425–600 μm; 
Sigma Cat No G-8772), 200 µl of yeast lysis solution (2% (v/v) Triton X-100, 1% (w/v) 
sodium dodecyl sulfate, 100 mM NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, in ddH2O) 
and 200 µl of Chloropane were added. The mixture was vortexed for at least 2 min to ensure 
the cell pellet has completely suspended to a single mixture. The mixture was centrifuged at 
132000 rpm for 10 min at room temperature. The top aqueous solution (containing DNA) was 
transferred to a new microcentrifuge tube, more 200µl of chloropane were added to the 
aqueous phase and vortexed briefly. The mixture was centrifuged as before. The DNA was 
precipitated by addition of 1/10 volume of 3 M sodium acetate pH5.2 (Roth, Karlsruhe, 
Germany) and 2.5 volume of absolute ethanol or (0.7 vol. of isopropanol), mixed by vortexing 
and centrifuged at 10,000g for 30 min at 4oC. The supernatant was discarded, and the DNA 
pellet was washed with 750 µl of 70 % ethanol and centrifuged at 10000g for 10 min at room 
temperature. Extra washes step(s) was performed to improve the plasmid transformation into 
bacteria. The DNA pellet was dried in a vacuum centrifuge. The dried plasmid DNA pellet is 
glassy in appearance. The DNA pellet is resuspended in TE buffer or DNase/RNase free 
ddH2O. 
 
2.2.10. Transformation of the plasmids isolated from the yeast into electrocompetent 
bacteria by electroporation 
The E. coli strain DH5alph was made electrocompetent (section 2.2.11). An aliquot of 70 µl 
elecrocompetent cells was thawed on ice. Then 1-2 µl from DNA plasmid were added to the 
electrocpmpetent cells and pipetted up and down to mix. The mixture was transferred to clean 
electroporation cuvette. The cuvette was placed in the cuvette holder of the electroporator 
(BioRad MicropulserTM) adjusted to Ec1 or Ec2 according to the diameter of the cuvette used. 
The bottom “pulse” was pressed until a constant tone was heard meaning that the cells were 
successfully transformed. Immediately 1 ml of 2 X YT medium was added to the cuvette 
containing the electroporated cells. The bacterial cells were transferred to a fresh 
microcentrifuge tube and incubated at 400 rpm at 37oC for 1.5 hr Meanwhile LB plate was 
warmed up at 37oC for at least 1 hr. The bacterial culture was centrifuged at 13200 rpm for 30 
Sec, ~ 800 µl were discarded from the supernatant. The pellet was re-suspended in the rest 
200 µl. these 200 µl which were plated (using glass beads) in LB medium containing the 
appropriate antibiotic. The LB plate was placed at 37oC overnight.  
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2.2.11. Preparation of Electrocompetent Ecoli (DH 5alpha) 
(http://www.its.caltech.edu/~bjorker/Protocols/Prep_of_electocomp_cells.pdf) 
The following materials were pre-chilled at 4oC, 1 L sterile 2 X YT medium (no antibiotics) 
stored at room temperature, 1L of sterile distilled H2O, and 150 ml of sterile 10% 
Glycerol/H2O. Then a single colony of E. coli selected from a fresh LB plate (very important 
to be a fresh LB plate streaked from a glycerol stock of E. coli competent cells, no matter, it 
can be either electero or chemical competent) for inoculating 10 ml 2XYT culture. The 
culture was incubated at 37oC at 250 rpm overnight (O/N). One litter of 2XYT medium was 
inoculated with the O/N culture (10 ml) and placed at 37oC shaker until the OD600 0.6-0.9 (log 
phase growth), the culture was removed and immediately placed on ice. From hereafter all the 
following steps were performed on ice. The 1 L culture was distributed equally to falcon 
tubes. The falcon tubes were centrifuged at 4000 rpm for 25 min at 4oC. The supernatant was 
removed immediately and the falcon tubes were re-placed on ice. The bacterial pellet was 
suspended gently in 200 ml of ice-cold sterile ddH2O. The suspension was re-centrifuged as 
before, and the supernatant was discarded. The falcons were placed on ice. The pellet was re-
suspended gently in 100 ml of ice-cold ddH2O and centrifuged as before. The supernatant was 
discarded; falcons were placed on ice, the pellets were re-suspended in 20 ml ice-cold 10% 
glycerol followed by centrifugation at 4000 rpm for 10 min at 4oC and discarding of the 
supernatant. The pellet was resuspended on 1 ml of ice-cold 10% glycerol; the suspension was 
aliquoted into 70 µl in 1.5 microcentrifuge tubes. The aliquots were snap-frozen with liquid 
nitrogen and stored at –80oC. 
2.2.12. Plasmid mini-preparation from E. coli, alkaline extraction  
The plasmid was extracted from the bacterial cells according to the protocol from (Birnboim 
and Doly, 1979). In brief, 1.5-2 ml was taken from the LB overnight culture containing the 
appropriate antibiotic. The bacteria were precipitated by centrifugation at the highest speed 
(14000 rpm) for 1 minute. The bacterial pellet was re-suspended in buffer I (section 2.1.9.A) 
either by vigorous vortexing or by pipetting up and down; no clumps should remain in the 
suspension. Then 250 µl of buffer II (section 2.1.9.A) were added to the suspension which 
was incubated at room temperature for 5 minutes, then 250 µl from buffer III (section 
2.1.9.A) were added, the mixture was gently inverted several times to mix followed by 
incubation for 5-10 minutes on ice. The mixture was centrifuged at maximum speed at 4oC for 
15 minutes to separate the cell debris and the chromosomal DNA from the plasmid DNA 
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which remains in the supernatant. The supernatant was taken carefully in a new 
microcentrifuge tube. The DNA was precipitated by addition of 0.8 volume isopropanol, 
followed by centrifugation for 15 minutes at 4oC at maximum speed. DNA pellet was washed 
2 times by 750 µl 70% ethanol (stored at -20oC) and re-centrifuged. The pellet was allowed to 
dry, and re-suspended for 1 hr in 100 µl from free DNase/RNase ddH2O or 1 X TE buffer. 
                                                                                                                                                                     
2.2.13. Re-testing MT2A clones for the re-activation of yeast reporter genes His3, Ade2 
and Mel1 with different bait proteins 
The yeast strain AH109 (Clontech Heidelberg, Germany) was independently co-transformed 
with the two bait constructs, Par17 and DYRK3-S cloned into the vector pGBKT7, and 
several different MT2A clones (pACT2-MT2A). Expression of these AD fusion proteins was 
tested by western blotting using a Gal4 AD monoclonal antibody (Raised in mouse, Labgen/ 
NatuTec, Frankfurt, Germany) and their DNA sequences were aligned manually. Moreover, 
one MT2A clone (BM2-5 from the screen of the bone marrow) was transformed with several 
bait constructs pGBKT7-DYRK3-S, pGBKT7-Par17, the control bait plasmid pGBKT7–lam, 
and pGBKT7 without any insert (empty pGBKT7). Transformed yeast cells were selected on 
SD –Leu, and for double transformations on SD –Leu –Trp medium. Well separated colonies 
(2-3mm) for each transformation were suspended in YPD medium, 10 fold serially diluted in 
96 well plate and transferred to SD –Trp –Leu and SD –Trp –Leu –His –Ade containing X 
alpha Gal.  The SD plates were incubated at 30oC for 7 days. 
 
2.2.14. SDS and western blot analysis for MT2A clones   
Proteins were extracted from the transformant yeast cells using Urea/SDS method prior to 
analysis by SDS-PAGE. Proteins were then separated in 12.5 % SDS-PAGE, transferred to a 
nitrocellulose acetate membrane and probed with antibody against the AD protein (Raised in 
mouse, Labgen/NatuTec, Frankfurt, Germany) as a primary antibody for overnight at 4oC and 
an anti-mouse HRP conjugate (Amersham, Freiburg, Germany), as a secondary antibody. The 
immune-reactive proteins were visualized by ECL (Western Blotting Reagents Thermo 
Scientific, Bonn, Germany).    
 
2.2.15. PCR amplification of MT2A clones  
The MTA insert was amplified using the forward 5' primer 5'– CTA TTC GAT GAT GAA  
GAT ACC CCA CCA AAC CC–3' and backward 3' primer 5'–GTG AAC TTG CGG GGT 
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TTT TCA GTA TCT ACG AT–3' (Matchmaker™ AD LD-Insert Screening Amplimer Set 
Clontech) with the following protocol: 12.25 µl PCR grade ddH2O, 2.5 µl 10x Complete 
Metabion Taq, 1.25 DMSO, 0.1 µl 5 LD amplimer, forward primer (100pmol/µl), 0.1 µl 3 LD 
amplimer reverse primer (100pmol/µl), 0.5 dNTPs (10mM), 0.3 µl Metabion Taq, 5 µl from 
each of MT2A templates using the following program: 94oC for 2 min for initial denaturation, 
94oC for 15 sec for denaturation, annealing 66oC for 15 Sec, 72oC for 2.5 min for extension 
(denaturation, annealing and extension for 35 cycles) and final extension 72oC for 5 min, 
block temperature 4oC and lid temperature was 110oC. 
 
2.2.16. Site-directed mutagenesis to recover MT2A reading frame 
The deletion of 2 nucleotides to bring MT2A in frame was done using Quick Change Site –
Directed Mutagenesis Kit (Agilent, Stuttgart, Germany), PCR was done by mixing the 
following: 2.5 µl of 10X reaction buffer, 1 µl of pACT2-MT2A (70ng/ µl) pACT2-MT2A, 
0.6 µl of the forward primer GCAACCTGTCCCGACTC–GCCGCCTCTTCAGCTCG, 0.6 µl 
of the reverse primer CGAGCTGAAGAGGCGGC– GAGTCGGGACAGGTTGC, 0.5 µl of 
dNTPs mix, and 19.8µl ddH2O to the final volume of 25µl. A little deviation from 
manufacturer’s protocol is that we added DMSO to the final concentration of 4%, to the 
protocol described in the kit manual.  
 
2.2.17. Expression and purification of the target protein, Parvulin17 for Phage display 
and Phage ELISA 
GST-tagged Par17 protein was expressed and purified as follows. The Par17 nucleotide 
sequence was cloned in-frame into the plasmid pET41-PreSc. The construct was chemically 
transformed in E. coli BL 21 competent cells. Protein expression from the plasmid pET41-
PreSc is under the control of the T7 promoter, which is induced by Lactose analog isopropyle 
ß-D-thiogalactoside (IPTG). LB medium was inoculated with the transformant cells and 
incubated at 37oC overnight. The overnight culture was diluted in 1 L of 2X YT medium 
containing Kanamycin (40µg/ml), followed by incubation at 37oC at 200 rpm until the OD600 
0.93 (~3 hrs), then 200µl 1M IPTG were added to the culture which was then incubated at 
24.5oC at 200 rpm overnight to induce the bacterial culture to express the GST fusion protein. 
The O/N culture was centrifuged at 6000 rpm for 15 min at 4oC. The supernatant was 
discarded and the pellet was re-suspended in 1X PBS (pH 7.4). Lysozyme from hen egg white 
(Fluka) powder (full spatula) was added to the bacterial cell suspension and mixed gently (no 
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air bubble should in the bacterial suspension) for ~ 40 min at 4o C. The suspension was 
subjected to microfluidizer, and then centrifuged at 35,000 rpm for 70 min at 4oC. The 
supernatant containing the GST fusion protein was taken for affinity chromatography. Par17-
GST fusion was purified using (column GST PrepTM FF16/10/GE Healthcare) with phosphate 
buffer saline pH 7.4 used for column equilibration, high salt buffer 400mM NaCl in 1x PBS 
used to wash away the unbound proteins. Par17-GST fusion protein was eluted with the buffer 
20 mM reduced glutathione in 1x PBS, pH adjusted to 7.4. A homemade PreSision enzyme 
(Jaremko et al., 2011) 1 µl/6mg protein is added to the GST fusion protein to release Par17 
from the GST domain. The GST fusion protein was placed at 4oC for at least 2 hrs, and 
concentrated using centrifugal filter units (Ultracel 3K from Millipore, Ireland) at 3000g at 
4oC. The released Par17 was purified using analytical gel filtration with the column 
(Superdex75 prepgrade, HiLoad 16/60, GE Healthcare); the column was equilibrated with the 
buffer 50 mM Tris-HCl pH 8, 25mM NaCl. SDS-PAGE was run to check for the purity of 
Par17; the SDS showed that Par17 is released from the GST domain.  
 
2.2.18. Expression and purification of 
15
N-labelled Parvulin 17 for NMR titration  
Overnight culture was prepared by inoculation of LB medium with E. coli BL21 transformed 
with the plasmid pET41 in which Par17-GST fusion was cloned. The culture was incubated at 
37oC at 200 rpm overnight. The following day, the O/N culture was diluted (1-2%) in 400 ml 
LB medium containing kanamycin to the final concentration of 50µg/ml. The LB medium 
was incubated at 37oC at 200 rpm until the OD600 0.7-0.8. The 400 ml were distributed in 
falcon tubes and centrifuged at 20oC, 4000 rpm for 15 min. The supernatants were discarded 
and the pellets were re-suspended in M9 medium (section 2.1.5.). The suspended bacterial 
cells were transferred to M9 medium containing Kanamycin. The culture was incubated at 
37oC at 200 rpm until the OD 600 0.7-09. The expression of Par17-GST fusion was induced by 
addition of 200 µl 1M IPTG to each 1L of M9 medium containing the re-suspended bacterial 
pellet. The culture was allowed to express the Par17-GST at 24.5oC overnight at 200 rpm. The 
purification of 15N Par17 was performed as exactly as for unlabelled Par17 used for phage 
display and Phage ELISA.  
 
2.2.19. Phage display screening of 7 and 12-mer peptide libraries for binding peptides of 
immobilized Par 17 on a Petri plate  
MATERIALS AND METHODS 
 
33 
 
The purified target protein, Par17 was diluted in the buffer (0.1 M) NaHCO3, pH 8.6 to the 
final concentration of 0.1mg/ml (normal concentration of target). Thereafter, 1.5 ml (150 µg) 
was immobilized in 60 X 15 mm Petri dish (Greiner Bio-One GmbH, Germany) by incubation 
overnight at 4o C under gentle agitation. The unbound protein was removed and the plate was 
blocked with 0.1 M NaHCO3 (pH 8.6), 5 mg/ml BSA, 0.02% NaN3 for ~1.5 hrs at 4
oC. Phage 
display 7 or 12-mer peptide library (New England Biolabs, NEB, Frankfurt, Germany) were 
screened using the to the manufacturer’s protocol (Ph.D.TM Phage Display libraries instruction 
manual, version 1.0-6/09). The plate was then washed 6 times with TBST (TBS + 0.1% [v/v] 
Tween-20).  For the first round approximately 2X1011 phage from the naive library were 
added into the coated plate and rocked gently for about 50 min at room temperature. Unbound 
phage were removed by washing 10 times with TBST. Bound phage were eluted with 0.2 M 
Glycine-HCl (pH 2.2), 1 mg/ml BSA. The eluted phage from the 1st round were amplified 
(section 2.7.16), and applied in the second round. The second round amplified eluate was 
applied in the third round. The selection stringency was increased in the 2nd and 3rd round by 
raising the concentration of tween 20 in TBST from 0.1 % to 0.5 %. After 3 rounds of 
panning, individual phage clones were collected from 3rd round tittering. The phage DNA 
were sequenced by GATC (Konstanz, Germany) using the –96 sequencing primer (NEB). In 
addition, the 7-mer library was screened against immobilized Par17, but with different 
strategy (reduced target concentration) where the target concentration was decreased to 10 nM 
in the 1st round and to 1 nM in the 2nd and the 3rd rounds. Elution was done with the target 
itself (Par17, 0.1 mg/ml in TBS buffer), and washing steps were performed as described 
above.  
2.2.20. Solution phase panning of 7-mer library with affinity beads capture using Par17 
as a target 
This type of panning was performed according to the protocol of Ph. D. TM Phage Display 
libraries instruction manual, version 1.0-6/09). Briefly, The glutathione (GSH) resin (50%) 
was immobilized on Handee TM Spin Columns (Pierce) by pipetting 50 µl from the resin on 
the column and 750 µl TBST 1% tween 20 were added, and then column is capped and 
vortexed gently to suspend the resin. The GSH resins were pelleted by centrifugation at 1250 
g for 0.5-1 min at room temperature. The supernatant was carefully discarded. The resins 
were suspended in 750 µl of blocking buffer (0.1 M NaHCO3 (pH 8.6), 5 mg/ml BSA, 0.02%) 
by gentle vortexing and incubated (with occasional mixing) at 4oC for at least 1 hr. In the first 
round, the target protein (2 picomoles of Par17-GST) was mixed with 2X1011 pfu from the 
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naive library to the final volume of 200 µl in TBST 1% tween 20. The mixture was incubated 
at room temperature for 20 minutes. The GSH resins were washed by addition of 750 µl of 
TBST 1 % tween 20 and centrifugation at 1250g for 0.5-1 min at room temperature. The 
supernatant was carefully discarded. The resins were washed 4 times pelleting them each 
time. The phage-target mixture was added to the blocked and washed resins, and incubated at 
room temperature for 15 min with occasional mixing. The resins were centrifuged at 1250g 
for 0.5-1 min at room temperature. The supernatant was carefully discarded; the resins were 
washed 10 times as described before. The bound phage were eluted with the 1 ml of Glycine 
elution buffer (0.2 M Glycine-HCl, pH 2.2, 1 mg/ml BSA), and immediately neutralized with 
150 μl of 1 M Tris-HCl, pH 9.1. The eluted phage were amplified, tittered and applied in the 
2nd round. The 2nd round amplified eluate was applied in the 3rd round. Starting from the 2nd 
round, a negative selection was performed were we incubated the phage with the resins (in the 
absence of target). The supernatant from this negative selection was then incubated with the 
target in a positive selection. Stringency was increased by raising the tween 20 concentration 
from 0.1% to 0.5 % in the 2nd and the 3rd rounds.    
 
2.2.21. Phage Display screening for binding peptides for C. symbiosum PinA  
A polystyrene Petri plate (the same used for Par17 panning) was coated with recombinant 
PinA of C. symbiosum 1.5 ml with concentration 0.1mg/ml in the buffer 0.1M NaHCO3 pH 
8.6. The plate was placed at 4oC overnight with gentle agitation. The following day, the 
coating solution was removed. The plate was blocked as mentioned above in the panning of 
Par17. About 2 X 1011 pfu from the naive library were applied into the coated and blocked 
plate followed by washings steps and elution of the bound phage also as mentioned above for 
the panning of Par17 immobilized on a Petri plate. The stringency of the panning was 
increased using the same strategy used for the panning of Par17 mentioned above. About 20 
sequencing templates from the a 3rd round tittering plate (containing <100 pfu) were purified 
by the protocol described below. The phage DNA were sequenced in GATC (Konstanz, 
Germany) using the primer –96 sequencing primer NEB. 
 
2.2.22. Amplification of the phage eluted from the panning  
The eluted phage from the panning were stored at 4oC overnight. The following day, the 
phage were added to an overnight culture of E. coli strain ER2738 (NEB, Frankfurt, 
Germany) diluted 1:100 in 20 mL of LB medium (containing tetracycline) in 250 mL 
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Erlenmeyer flask. Incubated for 4.5-5 hrs at 250 rpm at 37oC to allow the phage to amplify, 
then the culture was transferred to a sterile tube and centrifuged at 12000g for 20 min at 4oC. 
The supernatant was transferred to a fresh sterile tube and re-centrifuged. The upper 18 ml 
were pipetted in a fresh sterile tube prior to addition of 4ml of sterile 20% PEG/2.5 M NaCl, 
and incubated at 4oC overnight to precipitate the phage. 
 
2.2.23. Phage precipitation  
On the following day for amplification, the PEG-precipitated phage were centrifuged at 
12000g at 4oC for 30 min. The supernatant was discarded and phage pellet was re-centrifuged 
briefly to discard any supernatant. The pellet was suspended in 1 mL of sterile TBS and 
transferred to 1.5 microcentrifuge tube and centrifuged at 13200 rpm for 7 min at 4oC to pellet 
any remaining bacterial cells. The supernatant was then transferred to a new 1.5 
microcentrifuge tube and re-precipitated with 200 µl of 20 % PEG/2.5 M NaCl, incubated at 
4oC for ~ 1 hr. The PEG precipitation was centrifuged at 13200 rpm for 35 min at 4oC, the 
supernatant was discarded. The phage pellet was re-suspended in 200 µl of sterile TBS, 
centrifuged at 13200 rpm for 7 min at 4oC. The supernatant was transferred to a fresh 1.5 
microcentrifuge tube, these were the amplified phage. The amplified phage were tittered and 
taken for the following round. The rest were stored at –25oC after addition of an equal volume 
of sterile 86 % glycerol.  
 
2.2.24. Phage tittering 
Ten ml of LB medium containing tetracycline was inoculated with a colony of E. coli ER2738 
and incubated at 37oC for 4-8 hours (until the mid-log phase was reached). Agarose top was 
melted using microwave, and 3ml were distributed into sterile cultural tubes (These cultural 
tubes were kept at 45oC on a water bath) each tube per phage dilution. Phage pool was then 
10-fold serially diluted up to the dilution 104 for unamplified phage, or 1011 for amplified 
phage in LB medium. Two hundred µl from the bacterial culture were distributed into 1.5 
mico-centrifuge tubes each per phage dilution. Infection was done by addition of 10 µl form 
each phage dilution to a corresponding 200 µl bacterial culture. The infected bacterial cultures 
were incubated at room temperature for 1-5 min. The dilutions that were taken from 101-104 
for unamplified phage, and 108-1011for the amplified phage. Very quickly, the phage-infected 
bacterial culture was transferred to the cultural tube containing the 3 ml melted agarose, 
mixed by vortexing and immediately poured on a Petri plate (containing LB medium with 
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tetracycline and X Gal) each per dilution. The Petri plate was tilted several times to distribute 
the melted agarose; the plate was then placed at 37oC overnight.  
 
2.2.25. Rapid purification of phage clones sequencing templates  
Firstly, the plaques were amplified as follows: an overnight culture of E. coli ER2738 was 
diluted 100 times in LB medium containing tetracycline (0.02 mg/ml). For each phage clone 
to be purified 1ml was distributed in a cultural tube. Plaque forming units (pfu) were picked 
from an LB plate with <100 cfu and incubated for less than 18 hrs at 37oC, each pfu in a 
different cultural tube. Cultural tubes were incubated at 250 rpm, 37oC for 4.5-5 hrs. The 
cultures were each transferred to 1.5 micrcentrifuge tube, and centrifuged at 14000 rpm for 1 
min, at this step, 600-700 µl were taken from the supernatant for purification of sequencing 
template. The remaining supernatant was transferred to a fresh 1.5 microcentrifuge tube and 
re-centrifuged as before. The upper 80% supernatant was pipetted in a fresh microcentrifuge 
tube. An equal volume of 86% sterile glycerol is added to the upper 80% supernatant to 
prepare glycerol stocks which were stored at –25oC. Secondly, the phage in 600-700 µl were 
precipitated by 280µl of PEG/NaCl, the tube was inverted several times and left at room 
temperature for 20 min. The PEG precipitates were centrifuged at 4oC, 13200 rpm for 20 min, 
and then the supernatant was discarded. The tubes were centrifuged briefly, and the remaining 
supernatant was carefully discarded. The phage pellet was thoroughly suspended in 100 ml of 
Iodine buffer followed by 250 µl of absolute ethanol. This mixture was incubated at room 
temperature for 15min to preferentially precipitate phage DNA leaving most proteins in 
solution. The mixture was centrifuged at 13200 rpm for 20 min at 4oC, the supernatant was 
discarded. The pellet was washed with 0.6 ml 70% ethanol (stored at –25oC) and re-
centrifuged. The DNA pellet was dried under the vacuum (dried phage DNA pellet is white). 
M13 phage ssDNA templates were quantitated by running on agarose gel, 5µl of the 
suspended template should give a band of comparable intensity to 0.5 μg of purified single-
stranded M13mp18 DNA (NEB, Frankfurt, Germany).  
 
2.2.26. Phage ELISA 
An ELISA 96 well plate (immulon 4HBX, Thermoscientific, USA) was coated with 100 µl 
from Par17 (10-20 µg/ml) in the buffer 0.1M NaHCO3 pH 6.8 overnight. The following day, 
the target was removed by tapping the ELISA plate several times. The plate was blocked at 
4oC for at least 1 hr with 0.1 M NaHCO3 (pH 8.6), 5 mg/ml BSA, 0.02 % NaN3. Then the 
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plate was washed 6 times with TBST 5% tween 20 (Sigma-Aldrich, Munich, Germany) 
followed by addition of 109 pfu of phage in 100 µl to each well (10 wells), 2 blocked wells 
left without phage. The plate was incubated at room temperature for 1-2 hrs with agitation. 
The unbound phage were removed by washing the plate 6 times with TBST 5% tween 20. 
HRP conjugated anti-M13 phage Antibody (GE Healthcare) was diluted 1/5000 in the 
blocking buffer as recommended by the manufacturer, 200 µl were applied to each well 
followed by incubation at room temperature for 1 hr with agitation. Unbound antibody was 
removed by washing the plate 6 times with TBST 5% tween 20. The HRP substrate was 
prepared in advance by dissolving 22mg azino-bis (3-ethylbenzothiazole sulfonic acid) 
diammonium salt (ABTS, Sigma-Aldrich, Munich, Germany) in 100ml 50mM sodium citrate 
pH 4, the solution is filtered and stored at 4oC. Prior to the detection step, H2O2 was added to 
the HRP substrate solution. Then 200µl from the HRP substrate were applied to each well 
followed by incubation at room temperate (20-60 min) with gentle agitation. The plate was 
then read at 405nm. 
 
2.2.27. NMR titration of 
15
N-labelded Parvulin 17 with phage display-selected peptides 
SSFPPLLD and KHSPVHIGGGS-NH2  
The peptide SSFPPLLD was synthesized by ChemCube (Bochum, Germany). Aspartic acid 
(D) was added to the C-terminus to increase the peptide solubility. The peptide KHSPVHI 
was synthesized by JPT (Berlin, Germany). In the phage display (Ph.D.) peptide library, the 
C-terminus of the peptide is fused to pIII (minor coat protein of the phage) through the linker 
sequence GGGS. Therefore, we have added the sequence GGGS to the designed peptide, and 
we amidated the C-terminus to exactly mimic the situation in Ph.D. The 15N SOFAST-HMQC 
titration experiments were performed at 300 K on a 700 MHz Ultrashield NMR spectrometer 
(Bruker Biospin, Rheinstetten, Germany). For the NMR HMQC titration experiment (table 
2.1), peptide KHSPVHIGGGS-NH2 was dissolved to the final concentration of 30 mM in the 
buffer 50 mM Tris-HCl pH 7.5, 25mM NaCl. The peptide SSFPPLLD was dissolved in the 
buffer 50 mM potassium phosphate pH 6.5. 
Each peptide was titrated to Par17 (table 2.1) in 600 µl (550 µl 15N-labeled Par17, 0.40 mM 
and 50 µl Deuterium Oxide 99.9 atom % D Sigma Aldrich, Munich, Germany). 15N-labeled 
Par17 was dissolved in the same buffer in which each peptide was dissolved for the NMR 
titration. The total chemical shift differences upon addition of certain amount of peptide were 
calculated according to equation number 5. 
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                            ∆δ total =  √                                                (Eq. 5) 
where ∆δN is the chemical shift differences of N nucleus (ppm) and ∆δH is the chemical shift 
changes of H nucleus, and 0.154 is the weight factor of N (Ayed et al., 2001).  
To calculate the dissociation constant (Kd), the total chemical shift differences ∆δ total of each 
amino acid was plotted against the peptide concentration according to equation number 6 
(Sinnen, Ph.D thesis 2008).  
                 ∆δ total = S max   
x
  – 
–
                         (Eq.6) 
where ∆δ total is the total shift differences, S max is the hypothetical total shift reached at 
saturation, Eo is Par17 concentration, Lo is the ligand concentration, and Kd is the 
dissociation constant.  
 
Table 2.1. HMQC Titration steps of Phage display-selected peptides with 15N-labelled Par17. 
Titration step  KHSPVHIGGGS-NH2 (mM) SSFPPLLD (mM) 
1 0 0 
2 0.59 0.50 
3 0.97 0.97 
4 1.88 2.73 
5 4.1 4.29 
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3. Results  
3.1. The target proteins (Par17, Par14, and Par14 PPIase) for the Y2H were well-
expressed inside the yeast cell 
The bait proteins (Par14/17 or Par14 PPIase) for the Y2H were cloned in-frame to the vector 
pGBKT7. DNA bands were observed at ~ 396 bp and at ~ 291 bp corresponded to DNA of 
Par14 and Par14 PPIase respectively (figure 3.1). For Par17, bands were observed at ~ 471 bp 
corresponded to Par17 DNA (figure 3.2). We also observed bands at ~ 7.3 kbp matched the 
digested pGBKT7 (figures 3.1 and 3.2). 
In order to check the actual expression of the bait proteins fused to Gal4 DNA binding 
domain (Gal4 BD) inside the yeast cell, western blot analysis was performed. The yeast 
lysates were prepared using Urea/SDS method. Using antibody against Par14 PPIase domain 
as a first antibody and anti-rabbit as a second antibody, we could detect the bait proteins 
expressed inside the yeast cells fused to Gal 4 BD (figure 3.3). 
 
 
Figure 3.1. Digestion of the constructs pGBKT7-Par14 and pGBKT7-Par14 PPIase 
Agarose gel 1.5% stained with ethidium bromide showing the digestion products of the 
constructs pGBKT7-Par14 (lanes 11-15) and pGBKT7-Par14 PPIase (lanes 6-10) with the 
restriction enzymes, EcoRI and NdeI.  
 
 
Figure 3.2. Digestion of the constructs pGBKT7-Par14 and pGBKT7-Par14 PPIase  
Agarose gel 1.5% stained with ethidium bromide showing the digestion products of the 
construct pGBKT7-Par17 (lanes 1-10) with the restriction enzymes EcoRI and NdeI.  
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Figure 3.3. Western blot analysis for Gal4 BD fused to the bait proteins used in the Y2H 
screen 
From left to right, lane 1 is a molecular weight marker (Magic Mark, Invitrogen, Darmstadt, 
Germany), lane 2 is un-transfected AH109, lane 3-5 are Par17 fused to Gal4 BD, lane 6-8 are 
Par14 fused to the Gal4 BD, lane 9 and 10 are Par14 PPIase fused to the Gal4 BD.  
 
3.2. The bait proteins cannot activate the yeast reporter genes on their own  
To test for the autonomous activity of the Par14/17 and the Par14 PPIase domain fused to 
Gal4 BD, these target constructs were transformed independently with the empty library 
plasmid, pGADT7 which will express Gal4 AD only. The transformation mixtures were 
plated in SD –Trp –Leu to test for the success of transformation, and in SD –Trp –Leu –His –
Ade to check for the yeast reporter genes activation. After the incubation time (~1 week at 
30oC), the baits as well as positive controls (pGBKT7/pCL1 and pGBKT7-53/pGADT7-T) 
and negative control (pGBKT7-Lam/pGADT7-T) could grow in the medium selecting for the 
transformants (SD –Trp –Leu). Only the positive controls could grow in the medium selecting 
for the reporter genes activation (figure 3.4). This result indicates that the target constructs 
encoded by pGBKT7-Par14, pGBKT7-Par17, and pGBKT7-Par14 PPIase are autonomously 
inactive.  
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Figure 3.4. Colonies of yeast strain AH109 simultaneously co-transformed with target 
constructs and empty library plasmid 
Yeast colonies were observed in the medium SD –Trp –Leu, but not in the medium SD –Trp –
Leu –His  –Ade, indicating that the transformation was successful, and that Par17 and Par14 
and Par14 PPIase fused to Gal4 BD (target constructs) cannot activate the yeast reporter genes 
on their own. The plasmids pGBKT7/pCL1 encodes the full length wild type Gal4 protein. 
The plasmids pGBKT7-53 and pGADT7-T encode p53 and large T-antigen proteins 
respectively. It is known that p53 and large T antigen bind each other. The plasmids, 
pGBKT7-Lam and pGADT7-T encode human lamin C and large T-antigen proteins 
respectively; lamin C neither forms complexes nor interacts with most other proteins. 
 
3.3. Screening of the cDNA fetal liver and bone marrow libraries resulted in more than 
100 putative positive clones 
In order to find binding partners for Par17 protein we screened a fetal liver library using 
sequential yeast transformation and simultaneous co-transformation. More than 100 yeast 
colonies were observed in the high stringency medium SD –Trp –Leu –His –Ade. The bone 
marrow cDNA library was screened against Par17 by yeast mating (figure 3.5). The positive 
yeast colonies from both libraries were re-streaked in 2 Petri dishes of high stringency 
medium containing X alpha Gal. All the colonies grew and turned blue (figure 3.6) indicating 
an interaction between the two-hybrid proteins. The library plasmids were rescued from the 
yeast cells using the protocol of (Byrd and Arnaud, 2001), and transformed by electroporation 
into E. coli DH5 alpha.  
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Figure 3.5. Yeast zygotes (indicated with black arrows) after mating of the yeast strain 
AH109 harbours the bait protein (Par17) and yeast strain Y187 harbours the bone 
marrow cDNA library 
After ~ 20 hrs of mating, the zygotes were evident. In this field (figure 3.5), at least 3 zygotes 
were observed each one consisted of 3 lobes indicating a successful mating.  
 
 
Figure 3.6. More than 100 putative positive yeast colonies grew in the high stringency 
medium from screening of both libraries 
The yeast colonies grew and turned blue in the high stringency medium (these colonies may 
be harbouring candidate clones). The entire yeasts reporter genes (Ade2, His and Mel1) were 
activated indicating a physical binding between the two-hybrid proteins. 
 
3.4. All of metallothionein 2A clones obtained from the screenings of two libraries can 
activate the yeast reporter genes in the presence of their respective bait protein  
In search for interacting partners for the Par17 (Mueller et al., 2006) we obtained several 
independent clones with significant similarity to human metallothionein 2A (MT2A) on the 
nucleotide level. To examine the interaction of these clones, we performed a series of yeast 
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re-transformations. Four independent MT2A clones (FL-53, FL-127, FL-24, BM-2.5) from 
the libraries screening with Par17 were simultaneously co-transformed with the constructs 
pGBKT7-Par17 in the yeast strain AH109, and 2 different MT2 clones (BM-1, BM-8) from a 
previous screening done in our group, were simultaneously co-transformed with the construct 
pGBKT7-DYRK3-S in the AH109. These re-transformations were done to test for the ability 
of MT2A clones to re-activate the yeast reporter genes when they were independently re-
transformed with 2 different bait constructs. After incubation for 1 week at 30oC, yeast 
colonies were observed in the high stringency medium SD –Trp –Leu –His–Ade (SD–
WLHA). This result shows that all MT2A clones can activate the yeast reporter genes in the 
presence of their respective baits (figure 3.7).  
 
 
Figure 3.7. Colonies of yeast strain AH109 independently co-transformed with different 
MT2A clones and their respective target proteins 
Each horizontal row represents yeast strain AH109 colonies co-transformed with one of 
different constructs of pACT2-MT2A from fetal liver library clones (FL) FL-53, 127 or 24, 
and BM-1, BM-2.5, BM-8 from bone marrow library with either pGBKT7-Par17 or 
pGBKT7-DYRK3. The suffix behind FL and BM refers to the number of positive colony 
obtained in screenings. pGBKT7-53 expresses fusion of Gal 4 BD with murine p53, whereas 
pGADT7-T encode fusions of the Gal4 BD with SV40 large T-antigen. p53 and large T-
antigen interact in Y2H. pGBKT7-lam encodes a fusion of Gal4 BD with human lamin C that 
does not interact with most other proteins. All transformation mixtures were 10-fold serially 
diluted in 96 well plate and transferred to SD –Leu –Trp (SD –WL) medium containing X 
alpha Gal (left) and SD –Trp –Leu –His –Ade (SD –WLHA, right) and incubated at 30o C for 
6-7 days. 
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3.5. The MT2A mRNA is represented by many independent clones in the two cDNA 
libraries 
To compare the MT2A clones obtained from the human fetal liver and human bone marrow 
cDNA libraries, we aligned the nucleotide sequences of eight different clones (figure 3.8). 
Judging from PCR screening and restriction patterns, many more MT2A clones were obtained 
in our Y2H screens with the bait Par17. These aligned clones differ in the entire numbers of 
triplets between the 5´ end of the MT2A insert and linker sequence (GGCCGCGTCGAC) of 
the vector. In addition, they contain polyA tails of different lengths ranging from of 28 to 103 
nucleotides (figure 3.8). Due to the different lengths of their polyA tails and the nucleotides 
number, these eight MT2A clones cannot be a single redundant clone, but rather independent 
clones that resulted from different ligation processes. All aligned clones represent the same 
open reading frame (ORF), just differing by maximum of 10 amino acids C-terminal to linker 
sequence of the vector pACT2. The complete ORF of human MT2A as defined in the 
GenBank Ref. Seq. entry NM-005953 is contained within these clones. However, this 
sequence is not in-frame relative to Gal4 AD domain (+1 frame-shifted relative to the MT2A 
frame). Regarding the complexity of hybrid cDNA libraries, only ~16.6 % of the inserts will 
be in the correct reading frame relative to the AD domain (Two-Hybrid cDNA Library 
Construction Kit User Manual, protocol PT1113-1, version  PR71194). Therefore, it is most 
probably that all clones analyzed in this study encode the same out-of-frame protein that is not 
MT2A. This protein is not rich in cysteine as it is known for metallothioneins, but rich in 
proline and alanine (figure 3.9). 
 
 
Figure 3.8. Alignment of the DNA sequence of different MT2A clones obtained from the 
libraries screening 
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Distinct metallothionein 2A clones originated independently within 2 different cDNA 
libraries and differ in their 5’ ends and polyA tails. DNA sequences of several MT2A clones 
(BM-1, -2 and -8 from the screens with DYRK3-S (DY3) as bait, and BM2-5, FL-24, FL-53, 
FL-67, FL-106 and FL-127 as candidate clones from the screen with Par17 (P17) as a bait. 
The clones were aligned starting 5´end within their vector and EcoRI/NotI/SalI linker 
sequences (part of NotI and SalI sites underlined). The reading frame coming from the vector 
pACT2 is given below in single letter code. The point mutation in clone FL-67 results in a 
Val to Phe exchange. This clone also differs from the others by an extensive 3’ sequence 
downstream of the polyA tail. However, encoding a very similar AD fusion as the BM-8 
clone (This figure has been prepared by Dr. Jonathan W. Mueller). 
 
 
 
Figure 3.9. Alignment of the protein expressed by MT2A clones obtained by the 
screenings of the 2 cDNA libraries 
The out-of-frame MT2A proteins differ in length due to different in the number of the 
nucleotides between the adapter sequence GRVD and 5´ end of the MT2A inserts, which is 
not in-frame relative to Gal 4 AD. There is point mutation in FL-127, FL-24, and BM-2 
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resulted in exchange of  Val to Leu, and another one in BM-1 resulted in exchange of Leu to 
Phe.  
 
3.6. The protein encoded by the MT2A clones can activate the yeast reporter genes 
irrespective of the nature of the bait protein  
In order to test for the specificity of interactions of the fusion protein encoded by the pACT2-
MT2A constructs, one MT2A clone (BM.2-5) was independently co-transformed with 
pGBKT7-Par17, pGBKT7-DYRK3, pGBKT7-lam or with the empty bait vector (pGBKT7). 
Yeast colonies were observed in the high stringency medium (SD –Leu –His –Ade containing 
X alpha Gal), meaning that all the reporter genes His3, Ade2 and Mel1 have been activated 
(figure 3.10 upper panel). When we co-transformed pACT2-MT2A with the empty plasmid 
(pGBKT7) expressing the un-fused Gal4 BD, the transformants yeast could also grow in high 
stringency medium. Next, we asked whether the fusion protein encoded by the pACT2-MT2A 
binds the promoter or the promoter-associated proteins, to address this, we have transformed 
pACT2-MT2A alone into AH109. The transformant cells could grow in SD –Leu but not in 
SD –Leu –His –Ade containing X alpha Gal (figure 3.10 lower panel), meaning that the 
reporter genes have not been activated. This result gives 2 evidences; firstly, the protein 
encoded by the MT2A clones activates the yeast reporter genes regardless of the bait protein 
and even without bait protein. Secondly, the protein encoded by the MT2A clones does not 
bind the promoter or the promoter-associated proteins (figure 3.10). 
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Figure 3.10. Colonies of yeast strain AH109 simultaneously co-transformed with the 
pACT2-MT2A clones and the control plasmids in SD media 
Each horizontal row represents yeast strain AH109 colonies co-transformed with the pACT2-
MT2A construct (from bone marrow library, second screening, positive clone No.5, BM2-5) 
with either pGBKT7-Par17, pGBKT7-DYRK3, pGBKT7-lam or an empty bait vector 
pGBKT7-BD.Yeast colonies could grow in the high stringency medium whenever MT2A 
clone met Gal4 BD indicating an interaction between the 2 hybrid proteins. The last two rows 
are pACT2-BM2-5 and empty pGADT7 both of them were transformed in yeast cells 
independently, yeast colonies were not observed in the high stringency medium, indicating 
that the protein encoded by MT2A clones does not bind to the promoter or to the promoter-
associated proteins. pGBKT7-53 expresses a fusion of Gal4 BD with murine p53, whereas 
pGADT7-T encodes a fusion of the Gal4 AD with SV40 large T-antigen. p53 and large T-
antigen interact in Y2H. pGBKT7-lam encodes a fusion of the Gal4 BD with human lamin C 
which does not interact with most other proteins. All transformation mixtures were then 10-
fold serially diluted in 96 well plate and transferred to SD medium –Trp –Leu (–WL, left 
upper panel) and SD –Trp –Leu –His –Ade containing X alpha Gal (SD –WLHA+X, right 
upper panel), and SD –Leu containing X alpha Gal (SD –L, left lower panel) and SD –Ade–
His–Leu containing X alpha Gal (SD –AHL+X, right lower panel) all plates were incubated at 
30o C for 6-7 days. 
 
3.7. The expressed proteins from MT2A clones are different in molecular weights 
To learn more about the AD fusion protein encoded by MT2A clones, we performed SDS -
PAGE and western blot analysis. As described in materials and methods, the AD fusion 
proteins were probed using a primary antibody against Gal4 AD and anti-mouse as a 
secondary antibody. Bands of different sizes were observed ranging between 26-32 KD 
(figure 3.11 upper panel), indicating that the MT2A clones encode proteins of different 
molecular weights. In addition, the PCR amplification of the MT2A clones reveals that their 
molecular weights are ranging between 600-650 base pair (figure 3.12). 
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Figure 3.11. Western blot analysis and SDS-PAGE for the protein encoded by MT2A 
clones 
Upper panel is a western blot analysis of the protein encoded MT2A clones either from bone 
marrow (BM) or fetal liver (FL) library followed by the No. of the clone detected as positive 
in the library screen. Different bands were observed on the blot. The number on the left 
indicates the molecular weight marker. The lower panel is the transferred SDS gel after 
electrophoresis to show that almost equal amounts of the yeast lysates had been loaded.  
 
3.8. In-frame MT2A can no longer activate the yeast reporter genes on its own 
Next, we asked whether in-frame MT2A can activate the yeast reporter genes on its own. The 
MT2A was brought in-frame relative to Gal4 AD (figure 3.13). The yeast strain AH109 was 
simultaneously co-transformed with empty pGBKT7 and in-frame pACT2-MT2A. We also 
co-transformed empty pGBKT7 and out-of-frame pACT2-MT2A. Positive control was also 
co-transformed in parallel. The yeast AH109 cells that were co-transformed with empty 
pGBKT7 and out-of-frame MT2A as well as positive control could grow and turned blue in 
high stringency medium, SD –Trp –Leu –His –Ade containing X alpha Gal. Whereas, the 
yeast AH109 cells that were co-transformed with in-frame MT2A and empty pGBKT7 fail to 
grow in the high stringency medium, indicating that the AD fusion protein is no longer 
autonomously active (figure 3.14). This result shows that the protein encoded by the out-of-
frame MT2A clones and bind non-specifically in our Y2H system is not MT2A, but a 1+ 
frame-shifted MT2A, and that the MT2A does not bind non-specifically in Y2H system. 
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Figure 3.12. Agarose gel stained with ethidium bromide containing the PCR amplified 
MT2A clones 
From left to right, MW is 100 bp DNA ladder, BM2-5 is MT2A clone fished from the bone 
marrow library. FL-24, FL-53, FL-106, FL127 are MT2A clones from the screening of the 
fetal liver library. H2O is DNA-free water as a negative control.  
 
 
                         ggaaaaaatcgagatctctatgtgcttacccatacgatgtatcccgattacgctagcttg 
G  K  N  R  D  L  Y  V  L  T  H  T  M  Y  P  D  Y  A  S  L 
ggtggtcatatggccatggaggccccggggatccgaattcgcggccgcgtcgacgtccca 
G  G  H  M  A  M  E  A  P  G  I  R  I  R  G  R  V  D  V  P 
gcgaacccgcgtgcaacctgtcccgactcgccgcctcttcagctcgccatggatcccaac 
A  N  P  R  A  T  C  P  D  S  P  P  L  Q  L  A  M  D  P  N 
tgctcctgcgccgccggtgactcctgcacctgcgccggctcctgcaaatgcaaagagtgc 
C  S  C  A  A  G  D  S  C  T  C  A  G  S  C  K  C  K  E  C 
aaatgcacctcctgcaagaaaagctgctgctcctgctgccctgtgggctgtgccaagtgt 
K  C  T  S  C  K  K  S  C  C  S  C  C  P  V  G  C  A  K  C 
gcccagggctgcatctgcaaaggggcgtcggacaagtgcagctgctgcgcc 
A  Q  G  C  I  C  K  G  A  S  D  K  C  S  C  C  A 
 
Figure 3.13. The DNA sequence of MT2A clone brought in-frame relative to Gal4 AD, 
and the amino acid sequence (one letter symbol) of the translated protein 
The in-frame MT2A clones encode the correct MT2A (GenBank Ref Seq entry NM-005953), 
the vector reading frame is highlighted in light blue, and the primer-annealing site is 
highlighted in green.  
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Figure 3.14. Colonies of yeast strain AH109 independently co-transformed with in-frame 
or out-of-frame MT2A clone and the empty bait plasmid (pGBKT7) grew in SD media 
All the yeast transformants grew in SD –Trp –Leu (SD –WL). In-frame MT2A transformants 
failed to grow in SD –Trp –Leu –His –Ade + X alpha Gal (SD-WLHA+X), whereas out of-
frame MT2A and positive control transformants could grow.  
 
3.9. The panning of the 7 and 12-mer phage display (Ph.D.) libraries against Par17 
enriched for the same consensus peptide sequence 
Recombinant Par17 (figures 3.15, 3.16 and 3.17) was used to screen M13 Ph.D. peptide 
libraries for potential peptide binders. For this purpose, 100µg/ml (normal concentration) of 
recombinant Par17 in 0.1 M NaHCO3 (pH 8.6) was immobilized on a Petri dish through 
hydrophobic interactions and subjected to three rounds of panning. The bound phage were 
eluted with the general buffer for nonspecific disruption of binding interactions (0.2M 
Glycine-HCl (pH 2.2), 1 mg/ml BSA). Unbound phage were washed with Tris buffer saline 
TBST 0.1 % Tween 20 in the 1st round. The tween 20 concentration was raised to TBST 0.5 
% Tween 20 in the 2nd and the 3rd rounds to increase stringency in a step-wise manner. Table 
3.1 below is showing the titer of each round of panning of both Ph.D. libraries. Sequence 
analysis of enriched phage clones after the third panning yielded the consensus sequence X H 
S/T X V H Ø (where X can be any amino acid and Ø is a hydrophobic amino acid). This 
consensus sequence was found in 17 out of 24 clones sequenced from the 7-mer library 
panning, and 10 out of 16 sequenced clones from the 12-mer library panning (table 3.2).                      
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Figure 3.15. Affinity chromatography of Par17-GST 
Elution profile of the recombinant protein followed by absorption at 280 nm showing a peak 
of Par17-GST fusion protein eluted from the GST column using reduced glutathione 20mM in 
1x PBS pH 7.4. A large Par17-GST fusion peak was observed in the chromatogram. 
 
 
Figure 3.16. Gel filtration of recombinant Par17 and GST protein 
Elution profile of analytical gel filtration run followed by absorption at 280 nm showing a 
small peak of GST and a large peak of Par17 as observed in SDS gel. 
 
 
Figure 3.17. SDS gel for purification of Par17 
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SDS gel (15%) stained with Commassie brilliant blue showing the proteins content in some 
collected fractions from the gel filtration showing that Par17 (band at ~17 KD) is of 
appropriate purity, and therefore could be used for further assays.  
 
Table 3.1. Titers of panning of the peptide libraries against Par17 with normal 
concentration 
Approximate titer values of bound phage eluted from each round of panning of the 7 and 12-
mer libraries against immobilized Par17 on the Petri plate. 
Number of round Titers of 7-mer 
library  (pfu/10µl) 
Titers of 12-mer 
library (pfu/10 µl) 
1st round unamplified eluate 9.1X104 1X104 
1st round amplified eluate 1.1X1011 1X1011 
2nd round amplified eluate 8.3X1010 8.7X1010 
3rd round unamplified eluate 8.7X104 2.6 X105 
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Table 3.2. Peptide sequences deduced from the phage clones eluted after the 3rd round of 
panning against Par17 with normal concentration The 7-mer library (upper table), and 12-
mer library (lower table) were screened against Par17 with normal concentration. The 
conserved similar and homologous amino acid residues between peptide sequences are shown 
in bold. 
                               7-mer Ph.D library 3rd round 
N P L R V S L 1X 
N Q D V P L F 1X 
H D T P A P P 1X 
L P L T P L P 1X 
M P S N T V R 1X 
S Y S S F H R 1X 
S P T H G H D 1X 
T H S I V H P 1X 
L H S P V H L 1X 
I H S P V H I 4X 
K H S P V H I 4X 
K H S V V H V 1X 
Y H S V V H I 4X 
H H T G V H L 2X 
12-mer  Ph.D library 3
rd
 round  
 T       H S P V H V L A E H I 5X 
Y H S D V H C A N T C N 5X 
S H S V V H V T K N Q Y 3X 
W H T G V H I S A K P G 2X 
E L T N A Q I K L L W E 1X 
Consensus sequence         
X   H   S / T  X    V    H    Ø      
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3.10. Solution-phase panning against Par17-GST, and panning against immobilized 
Par17 (with reduced concentration) enriched for the same phage clones 
To find peptides that bind with high affinity to Par17, Par17 concentration was decreased to 
10 nM in the 1st round and to 1nM in the 2nd and 3rd rounds. The elution was performed with 
Par17 itself. Three rounds of panning (table 3.3) were performed as described in the material 
and methods. After the 3rd round, 14 phage clones were purified and sequenced (Table 3.4). 
In a solution-phase panning experiment, Par17-GST fusion protein was immobilized in 
glutathione resins to avoid partial denaturation of the target protein, and to make all binding 
sites accessible to ligands. After the 3rd round of panning (table 3.5), 15 phage clones were 
purified and sequenced (table 3.6). From both types of panning mentioned above we found 
the same phage-borne peptides, SSFPPLL (the most frequented), LPLTPLP, and GKPMPPM 
(tables 3.4 and 3.6).  
 
Table 3.3. Titers of 7-mer library panning against Par17 with reduced concentration 
Approximate titer values of bound phage eluted from each round of panning of the 7-mer 
library against immobilized Par17 (with reduced concentration) on a Petri plate. 
Number of round Titre ( Pfu/10)  
1st round unamplified eluate  2.7X104 
1st round amplified eluate 2.5X1011 
2nd round amplified eluate 9X1010 
3rd round unamplified eluate 2.8X104 
 
 
Table 3.4. The amino acid sequences deduced from the phage eluted after the 3
rd
 round 
of panning against Par17 with reduced concentration 
In this panning the target concentration was reduced to 10 nM in the 1st round and to 1 nM in 
the 2nd and the 3rd rounds.    
L P L T P L P 5 X 
S S F P P L L 8 X 
G K P M P P M 1 X 
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Table 3.5. Titers of solution-phase panning with Par17-GST  
Approximate titre values of bound phage eluted from each round of panning of the 7-mer 
library against Par17-GST immobilized on glutathione resins.  
      Number of round Titre ( pfu/10)  
1st round unamplified eluate  3X104 
1st round amplified eluate 2X1011 
2nd round amplified eluate 1.7X1010 
3rd round unamplified eluate 7X104 
 
 
Table 3.6. The amino acid sequences deduced from the phage eluted after the 3rd round 
of solution-phase panning with Par17-GST 
In this panning, the target protein (GST-Par17) was immobilized on glutathione resins.  
 L P L T P L P 1 X 
 S S F P P L L 13X 
 G K P M P P M 1 X 
 
 
3.11. The enriched phage-borne peptides bind Par17 and neither the plastic nor Par17-
related protein 
In order to test the phage-borne peptides enriched in the phage display panning in term of 
affinity and specificity, phage ELISA experiments were performed. In the first ELISA 
experiment (figure 3.18), the phage-borne peptides were independently (109pfu from each) 
incubated with the target (Par17) protein, or with a target-related protein, hPin1. The phage 
bindings were assessed using M13 antibody (Ab), this Ab was Horse Radish Peroxidase HRP 
conjugated. We used azino-bis (3-ethylbenzothiazole sulfonic acid) diammonium salt (ABTS, 
Sigma) as an HRP substrate. This substrate produces a soluble end product that is green in 
color and can be read spectrophotometrically at 405 nm. Our phage ELISA suggests that the 
phage borne-peptide KHSPVHI binds Par17 with the highest affinity and specificity than the 
other phage-borne peptides (figure 3.18). The phage-borne peptide SSFPPLL binds Par17 
with a relatively higher affinity than to Pin1 (figure 3.18). In another ELISA experiment 
(figure 3.19). The phage-borne peptide KHSPVHI was compared with phage-borne 12-mer 
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peptides all of them containing the motif X H S/T X V H Ø. Here, the phage-borne peptides 
were independently (109pfu from each) incubated with Par17 coated or uncoated wells.  
This ELISA experiment indicates that the phage-borne peptide sequence XHSXPVHØ (where 
X can be any amino acid and Ø is a hydrophobic amino acid) binds Par17 with a moderate 
affinity, and it binds the BSA-blocked plastic with a minimal affinity (figures 3.18 and 3.19).  
 
 
Figure 3.18. Phage ELISA showing the ability of the phage-borne 7 and 12-mer peptides 
to bind Par17 
Peptide1 (PD1) is SSFPPLL, PD2 is LPLTPLP, PD3 is KHSPVHI, and PD4 is 
NRPDSAQFWLHH. ELISA 96 well plate was coated with Par17 or hPin1 (10-20µg/ml). 
One raw (10 wells) for each phage to be tested, 109 pfu were applied in each well. The ELISA 
plate was read at 405nm, mean values and standard deviations were taken for the 10 coated 
wells. 
 
 
Figure 3.19. Phage ELISA showing the ability of the phage-borne 7 and 12-mer peptides 
to bind Par17 (blue bars) and not BSA-blocked plastic (red bars) 
Peptide 1 (PD) 1 is WHTGVHISAKPG, PD2 is SHSVVHVTKNQY, PD3 is 
YHSDVHCANTCN, PD 4 is THSPVHVLAEHI, PD 5 is ELTNAQIKLLWE, and PD 6 is 
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KHSPVHI, ELISA 96 well plate was coated with Par17 (10-20µg/ml). One raw was taken 
for each phage to be tested. Ten wells were coated and 2 wells were left uncoated. Phage 109 
pfu were applied in each well. Mean values and standard deviations were taken for the 10 
coated wells, and for the 2 uncoated wells. Since the peptides are not rich in aromatic amino 
acids, we assumed that they are not plastic binders. Therefore, only 2 wells were left uncoated 
to test the ability of the peptides to bind the polystyrene plastic plate. 
 
3.12. The peptide KHSPVHIGGGS-NH2 binds in a hydrophobic pocket in the PPIase 
domain of Par17  
To confirm binding of the phage display-selected peptide KHSPVHIGGGS-NH2 to Par17 
(table 3.2), and to map the binding surface of Par17, NMR titration experiments were 
performed (figure 3.20). The peptide KHSPVHIGGGS-NH2 binds Par17 with low binding 
affinity or binding affinity in high micromolar range (table 3.7). The dissociation constant 
(Kd) was estimated using NMR chemical shift changes (figure 3.21), using the program 
SigmaPlot 11. The peptide KHSPVHIGGGS-NH2 binds Par17 with a Kd of ~ 0.7 mM. 
Judging from the region of residues exhibiting significant chemical shift changes upon 
HMQC titration (figure 3.21), the binding occurs in the loop between β sheet 2, and α helix 3. 
The helix 3 is also involved in binding (figure 3. 23). The Par14/17 residues showed 
significant chemical shift changes were Val40, Met52, Ala76, Asp81, Met90, Val91, Phe94, 
Gln95, Glu96, and Ala98 (figures 3.21and 3.22).                                                                                        
                                    
 
Figure 3.20. 
15
N-SOFAST-HMQC of spectrum of 
15
 N-labeled Par17 
Full-length Par17 was expressed in E. coli and purified (as described in materials and 
methods, section 2.2.18).    
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Figure 3.21. Parts of 
15
N-SOFAST-HMQC spectra of ~ 0.4 mM 
15
N-labeled Par17 alone 
(green contour), and Par17 with ~ 4 mM KHSPVHIGGGS-NH2, (red contour) 
The amino acid residues with significant chemical shift perturbations are indicated with one-
letter symbol, the number of residue, and the direction of the chemical shift.  
 
Table 3.7. Kd values of Par17 amino acid residues exhibiting significant chemical shift 
changes upon titration with the peptide KHSPVHIGGGS-NH2 
Approximate Kd values and standard (Std) errors of the amino acids (and their mean) with 
significant chemical shift changes upon titration of 15N-labeled Par17 with the peptide 
KHSPVHIGGGS-NH2.  
Amino acid (aa) residue of Par17 Kd (mM) Std Error 
Glutamine (Q95) 0.8 0.3 
Glutamic acids (E96) 0.7 0.06 
Alanine (A98) 1.7 0.9 
Aspartic acid (D81) 0.3 0.18 
Methionine (M52) 0.04 0.02 
Mean of Kd of all the aa  0.7 0.30 
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Figure 3.22. Curves of some 
15
N-labelled Par17 amino acid residues showing significant 
chemical shift changes (and their mean value) upon titration with the peptide 
KHSPVHIGGGS-NH2 
The program (SigmaPlot11) was used for curves-fitting and Kd calculation. Total chemical 
shift changes (ppm) of each of the residues and their mean are plotted against the peptide 
concentration (protein: peptide, 0.4mM: 4mM).  
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Figure 3.23. Mapping of the binding surface of the peptide KHSPVHIGGGS-NH2 on the 
molecular surface of Par17 
The amino acid residues showing significant chemical shift changes upon peptide titration are 
sown in red, and indicated with numbers and arrows in (A) 3 dimensional surface structure of 
Par14 (PDB. ID 1EQ3). (B) Par14 cartoon structure. This figure was generated using 
PyMol1.3. 
 
3.13. The peptide SSFPPLLD binds Par17 PPIase domain at the postulated binding 
pocket  
To map the binding surface of Par17 with the peptide SSFPPLLD selected from the Phage 
display (tables 3.4 and 3.6), and to calculate the binding constant (Kd) we performed NMR 
titration studies. Our NMR data suggest that the peptide SSFPPLLD binds Par17 with a Kd of 
~ 1.6 (table 3.8 and figure 3.25) also at its PPIase domain (figures 3.24 and 3.26). Par17 
amino acid residues exhibited significant chemical shift changes were His48, Gly49, Met52, 
Thr86, Met90, Phe94, Glu96, Val91, and Phe111 and may be Phe120 (figures 3.24 and 3.25).  
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Figure 3.24. Part of 
15
N-SOFAST-HMQC spectra of ~ 0.4 mM
 15
N-labelled Par17 alone 
(green contour), and Par17 with ~ 4.3 mM the peptide SSFPPLLD (red contour) 
The amino acid residues with significant chemical shift perturbation are indicated with one-
letter symbol, the number of residue and the direction of the chemical shift.  
 
Table 3.8. Kd values of Par 17 amino acid residues exhibiting significant chemical shift 
changes upon titration with the peptide SSFPPLLD 
Approximate Kd values and standard (Std) errors of the amino acids (and their mean) with 
significant chemical shift changes upon titration of 15N-labeled Par17 with the peptide 
SSFPPLLD. 
Amino acid (aa) residue of Par17 Kd (mM) Std Error 
Threonine (T86) 1.6 1.5 
Methionine (M90) 0.71 0.55 
Phenylalanine (94) 3.1 2.3 
Glutamic acid (E96) 1 1.65 
Mean of Kd of all the aa 1.6 1.4 
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Figure 3.25. Curves of some 
15
N-labelled Par17 amino acid residues showing significant 
chemical shift changes (and their mean value) upon titration with the peptide 
SSFPPLLD 
The program (SigmaPlot11) was used for curves-fitting and Kd calculation. Total chemical 
shift changes (ppm) of each of the residues (and their mean value) are plotted against the 
peptide concentration (protein: peptide, 0.4mM: 4.3mM). 
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Figure 3.26. Mapping of the binding surface between Par17 and the peptide SSFPPLLD 
The residues exhibiting chemical shift changes are shown in red and indicated with No. and 
arrows in (A): Three dimensional surface structure of Par14, PDB. ID 1EQ3 (B): Par14 
cartoon structure. This figure was generated using PyMol1.3. 
 
3.14. The panning of the 7-mer library against C. symbiosum PinA enriched for 2 
peptides, HKRPRNN and HQSPWHH 
In order find peptide binding partners for C. symbiosum PinA, we screened a 7-mer phage 
display library from NEB. C.symbiosum PinA (0.1 mg/ml) was immobilized on a polystyrene 
plate. After 3 consecutive rounds of panning, elution and amplification (Table 3.9), two 
peptides HKRPRNN and HQSPWHH were enriched (table 3.10). The stringency of panning 
was increased in washing steps by raising the tween 20 concentration of TBST from 1% in the 
1st round to 5% in the 2nd and the 3rd rounds. Washings steps were followed by elution of the 
bound phage with 0.2 M Glycine-HCl (pH 2.2), 1 mg/ml BSA.  
We also found the peptide HAIYPRH, a dominating target-unrelated peptide (Brammer et al., 
2008), in our 3rd round elaute. Next, we performed phage ELISA to learn more about the 
phage-borne peptides enriched in the panning in term of affinity and specificity for C. 
symbiosum PinA. The phage-borne peptides were independently (109pfu from each) incubated 
with the target protein C. symbiosum PinA. The phage bindings were assessed with HRP-
conjugated M13 antibody. Azino-bis (3-ethylbenzothiazole sulfonic acid) diammonium salt 
(ABTS) was used as an HRP substrate, the products for this substrate is green and can be read 
at 405 nm. Our phage ELISA suggests that the phage borne-peptides HKRPRNN and 
HQSPWHH bind C. symbiosum PinA with moderate affinity (figure 3.27). Therefore, these 
peptides were taken for NMR titration to study the binding sites of C. symbiosum PinA. 
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Our NMR data indicate that the peptide HQSPWHH binds in a big hydrophobic cleft formed 
from helix II, β sheet II and helix III. The amino acids residues that exhibited chemical shift 
changes were Phe31, Gly32, Gly42, Ser44, Gly53, Gly55, Gly57, Lys58, Val60, Phe83, 
Gly84, and Lys89 (figure 3.28). 
 
Table 3.9. Rounds of C. symbiosum PinA panning  
Approximate titre values of rounds of the 7-mer library screening against the Pin A of C. 
symbiosum. 
     Number of round Titre ( Pfu/10 µl) 
1st round unamplified eluate  4 X 104 
1st round amplified eluate 1.24 X 1011 
2nd round amplified eluate 3.2X1010 
3rd round unamplified eluate 5.1X104 
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Table 3.10. The amino acids sequences that were deduced from the phage DNA selected 
from the 3
rd
 round of screening of the 7-mer library (NEB) against PinA of C. 
symbiosum 
The peptides HKRPRNN and HQSPWHH were selected 5 and 3 times respectively from 20 
sequenced phage clones. All other peptides were detected once. Conserved residues between 
phage clones shown in bold. The phage-borne peptide HAIYPRH was found in the 3rd round 
phage pool.              
H K R P R N N 5X 
H Q S P W H H 3X 
A P S P M I W 1X 
W D P S Q M R 1X 
S L H S  R P N 1X 
T I E Q H P P 1X 
V Y L T G P S 1X 
L D R A N V F 1X 
N Q L T T L N 1X 
S H T I R M L 1X 
Y V H Q Q R H 1X 
T M C I Y C T 1X 
G L C C S R L 1X 
H A I Y P R H 1X 
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Figure 3.27. Phage ELISA for the peptides (PD1 is HKRPRNN and PD 2 is HQSPWHH) 
enriched in the screening of the 7-mer library with C. symbiosum PinA as a target 
protein. An ELISA 96 well plate was coated with C. symbiosum  PinA (0.1mg/ml). One raw 
for each phage to be tested, 8 wells were coated with C. symbiosum  PinA. Phage (109 pfu) 
were applied to each well. The mean values and standard deviation were taken for the 8 
coated wells of each phage.          
                                                                
                                                                                  
 
Figure 3.28. Cenarchaeum symbiosum PinA binding pocket and flexible region  
Cenarchaeum symbiosum PinA PDB. ID 2RQS, (A) The amino acid residues (shown in red 
here) showing chemical shift changes when C. symbiosum PinA titrated with the peptide 
HQSPWHH. (B) The flexible region shown in red from Ser44 to Gly49. This figure was 
generated using PyMol 1.3.  
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4. Discussion  
4.1 MT2A is a target unrelated or a specific binder in the Y2H system 
During the screening of two cDNA libraries (figures 3.5 and 3.6) from different tissues with 
Par17 (Mueller et al., 2006), MT2A (figure 3.8) has been detected as false positive several 
times in several screenings in the Y2H Gal4 system (figures 3.7 and 3.10). It is not unusual to 
detect false positives in the screening, but Metallothionein has been reported by other 
researchers as genuine interaction partner, and they confirm the interaction with different 
alternative methods (Rao et al., 2003; Gonçalves et al., 2008). Furthermore, MT2A was 
described as a binding partner for different bait proteins using only the Y2H, and without 
checking the correct reading frame of MT2A (Bai et al., 2005; Pope and Lee, 2005, Thijssen 
et al., 2006). On the other hand MT2A has been reported as a false positive in Y2H, therefore 
it was excluded from the list of candidate clones (Bosch-Comas et al., 2006; Wang et al., 
2008).  
 
It was reported that a large ORF not in-frame relative to Gal4 AD will correspond to the 
expressed protein (Matchmaker™ Library Construction & Screening Kits User Manual, 
Clontech, Protocol No. PT3955-1, Version No. PR792376, published 2007). In agreement 
with this, the length of the fusion protein expressed inside the yeasts as determined by western 
blotting (figure 3.11) is between 25 and 32 kDa; larger than the predicted molecular weight of 
the Gal4 AD-MT2A fusion (~ 24 kDa). Yeasts can sometimes correct not in-frame clones by 
frame-shifted translation (Fromont-Racine et al., 1997). But this is unlikely to be in our case 
where we have different protein sizes from MT2A clones, and the out-of-frame MT2A 
translated to a protein that is rich in proline (figure 3.9), and interact non-specifically in Y2H 
(figures 3.7 and 3.10 upper panel), whereas in-frame MT2A do not (figures 3.13 and 3.14).   
 
We show that MT2A clones, which are +1 out-of-frame relative to Gal4 AD (figure 3.8) can 
activate the reporter genes of the yeast strains AH109 and Y187 when they were co-
transformed with pGBKT7-Lam or with empty pGBKT7 and as long as Gal 4 BD existed 
(figure 3.10 upper panel).  
In the cDNA libraries, only ~ 16.6% of the inserts will be in the correct reading frame relative 
to Gal4 AD (Two-Hybrid cDNA Library Construction Kit User Manual, Protocol PT1113-1, 
version PR71194). The protein that is expressed inside the yeast from the out-of-frame MT2A 
clones is not MT2A, but a +1 frame-shifted MT2A (Elfaki et al., 2011). We show that MT2A 
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in the correct reading frame relative to Gal4 AD domain (figure 3.13) can no longer activate 
the yeast reporter genes, but the +1 frame-shifted MT2A did (figure 3.14), this results indicate 
that MT2A is not a sticky protein (Elfaki et al., 2011). It is most probably that the protein that 
was described as false positive (Bosch-Comas et al., 2006, Wang et al., 2008) is not MT2A, 
but a +1 frame-shifted MT2A. 
When pACT2-MT2A was co-transformed with pGBKT7-lam, the yeast cells could grow in 
the high stringency medium (figure 3.10 upper panel) that means, the entire reporter genes 
were activated, which is inconsistent with (Bai et al., 2005). Moreover, when we co-
transformed pACT2-MT2A with empty plasmid (pGBKT7) expressing the un-fused Gal4 BD, 
the transformant yeast cells could grow in high stringency medium, meaning that pACT2-
MT2A construct encodes a fusion protein alone can activate the yeast reporter genes. These 
data indicate that MT2A clones (which are not in-frame relative to Gal4 AD) generate a 
technical false positive in Y2H. It was reported that in rare cases the AD fusion protein can 
activate the reporter genes on its own, possibly by binding to the promoter or to the promoter-
associated proteins (Finley, 2007). To address this issue, we have transformed it alone into 
AH109. The transformant cells could grow in SD –Leu but not in SD –Leu –His –Ade 
containing X-alpha-Gal (figure 3.10 lower panel) indicating that the reporter genes were not 
activated, and the encoded protein does not bind the promoter or the promoter-associated 
protein. This is in agreement with (Pope and Lee, 2005). It is therefore, the studies which 
have proposed that MT2A as a binding partner for their bait proteins using only the Y2H, and 
without checking the correct reading frame of MT2A (Bai et al., 2005; Pope and Lee, 2005, 
Thijssen et al., 2006), further verifications of the interaction of their bait protein with MT2A 
are needed.  
Perhaps the +1 frame-shifted MT2A fused to Gal4 AD produces a promiscuous protein. Since 
this protein is rich in proline, it can form sticky stiff arms as reported for the proline rich 
regions that bind other proteins rapidly and reversibly (Williamson, 1994). However, a 
coincidental specific protein–protein interaction with Gal4 BD cannot be excluded.     
 
Among the other clones that we have obtained in our screenings is the zink finger protein 
which is known to be a technical false positive (Hengen, 1997). We also found vitronectin 
within our screens. It did not bind Gal4 BD when it was transformed with the empty 
pGBKT7, but it binds another construct of pGBKT7 (pGBKT7-DIRK3) indicating that its 
interaction with Par17 “in our Y2H screenings” is rather nonspecific.  
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4.2. Two peptide sequences were enriched in the panning of 7 and 12-mer Ph.D. libraries 
against Par17, a consensus peptide sequence and a phage pool-dominating peptide 
Our screening of Ph.D. 12 and the 7-mer peptide libraries against Par17 (with a normal 
concentration) enriched one consensus sequence, XHSXVHØ (table 3.2), where X can be any 
amino acid, and Ø is a hydrophobic amino acid. This motif was present in many different 
peptides in the 3rd round from both Ph.D. libraries (table 3.2). It represents ~ 70 % of the 
phage-borne peptides of the 3rd round from the 7-mer library panning. Similarly, it is found in 
~ 62% of the phage-borne peptides of the 3rd round from the 12-mer library panning (table 
3.2).  
To obtain peptides bind with a high affinity, we increased the stringency of panning by 
reducing the target concentration to the minimal. Using this strategy we obtained the phage-
borne peptide SSFPPLL (table 3.4). This peptide was also enriched when we applied the 
solution-phase panning against Par17-GST (table 3.6), where it was almost dominating the 
phage pool of the 3rd round. We propose that the phage-borne SSFPPLL peptide is a “sib” 
clone binds Par17, but with low affinity. It has the ability to amplify and dominate the phage 
pool, probably because it has developed an amplification advantage over other phage of the 
library (Troubleshooting Forum, Molecular Biology Techniques Q&A, Bio-Techniques, doi 
10.2144/000113537, 2010, 49: 789-791).   
With phage ELISAs, we demonstrated that the phage-borne peptides containing the motif 
(XHSXVHØ), and the phage-borne peptide SSFPPLL bind Par17 (figures 3.18 and 3.19). 
However, the phage-borne peptides containing the motif (XHSXVHØ) bind Par17 with a 
relatively higher affinity than the phage-borne peptide SSFPPLL. For the motif, XHSXVHØ, 
our phage ELISAs suggest that Pro at position i 0 can be replaced by most amino acids. His at 
position i –2 is required for the binding, but it can be replaced by Leu with a decrease in 
ELISA OD at 405 nm. Ser at position i –1 is also required for the peptide binding, however, it 
can be substituted by Thr. Val and His at position i +1 and i +2 respectively must be present 
for a good binding, while i +3 must contain a hydrophobic amino acid (figures 3.18 and 3.19). 
 
Our NMR results indicate the peptide KHSPVHIGGGS-NH2 binds Par17 with a Kd of ~ 0.7 
mM, (STDEV ~ 0.6) whereas, the peptide SSFPPLL binds Par17 with a Kd of 1.5 mM 
(STDEV ~ 1.06). However, from our Ph.D. and Phage ELISA results we would have 
expected higher binding affinities (lower micromolar range). Probably in this case such short 
peptides are not sufficient for a strong binding (Landgraf et al., 2004).  
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Our NMR data suggest that the peptide KHSPVHIGGGS-NH2 binds Par14/17 PPIase domain 
(figures 3.22 and 3.23). The Par14/17 residues showed significant chemical shift changes 
were Val40, Met52, Ala76, Asp81, Met90, Val91, Phe94, Gln95, Glu96, and Ala98 (figures 
3.21 and 3.22). For the peptide SSFPPLLD which also binds Par14/17 PPIase domain, Par17 
amino acid residues exhibited significant chemical shift changes were His48, Gly49, Met52, 
Thr86, Met90, Phe94, Glu96, Val91, and Phe111 (figures 3.24, 3.25 and 3.26). Phe120 also 
probably exhibited small chemical shift changes.  
 
The amino acid M52 is not a round the PPIase active site (figure 3.23). Perhaps it exhibited 
chemical shift changes due to Par14/17 conformational changes or structural rearrangement. 
 
The residues Met90, Val91 and Gln95 are forming the rim of a hydrophobic core in the 
molecular surface of Par14/17, whereas, Phe94 is lying at the bottom of this core (figures 3.23 
and 3.26). Met90, Phe94, Val91 were proposed to be among the residues of Par14 active site 
(Sekerina et al., 2000; Terada et al., 2001; Jaremko et al., 2011). Our data suggest that this 
hydrophobic core is the PPIase active site of Par14/17. 
 
The phage display-derived peptide sequence (XHSXPVHØ) can be aligned with significant 
homology in many proteins. If this peptide is available for interaction in the native protein 
structural context, we can expect an interaction between XHSXPVHØ-containing protein and 
Par14/17. For instance mixed lineage kinase 4, MLK4 (mitogen activated protein kinase 
kinase kinase, Ref. Seq NP_115811.2) can be a good candidate. The peptide sequence 
XHSXPVHØ can be aligned two times with the amino acid sequence of MLK4. In MLK4 
amino acid sequences from 935 to 941 there is the peptide KHSTVHI, and from 115 to 119 
there is sequence SPVHV. Both of these peptides KHSTVHI and SPVHV from MLK4 
contain the Ph.D. selected motif (XHSXPVHØ). Weak protein-protein interactions occur in 
vivo (Vaynberg and Qin, 2006). However, other amino acid residues from both proteins may 
contribute to the interaction, and thereby increasing the binding affinity. Therefore Par14/17 
can bind this motif in vivo if it is available for interaction and solvent-exposed in the protein 
natural context. In addition our peptide can be used to design a substrate or an inhibitor for 
Par14/17 PPIase catalytic assay.  
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We also found the peptide LPLTPLP in our screening for peptide binders for Par17 as 1 clone 
among 15 sequenced clones from the 3rd round (table 3.2). This panning was done by 
immobilizing 100µg/ml of Par17 protein, eluting with the general buffer for nonspecific 
disruption of binding interactions (0.2 M Glycine-HCl (pH 2.2). The peptide LPLTPLP was 
also enriched when we reduced the target (Par17) concentration to the minimal (table 3.4), 
and when we performed the solution-phase panning against Par17-GST (table 3.6). 
 
In a Ph.D. panning against the high mobility group 1 (HMGB1), the peptide LPLTPLP was 
selected several times after 3 rounds of panning (Dintilhac and Bernués, 2002). The amino 
acids sequence LPLTPLP could be aligned with 100 % homology with the amino acid 
sequence of the Groucho protein, amino terminal enhancer of split (AES) from 140-146. The 
interaction of HMGB1-AES was shown by a pulldown experiment (Dintilhac and Bernue´s, 
2002). 
It has been shown that Par14 binds the DNA and shares some sequence similarity with HMG 
proteins (Surmacz et al., 2002). Therefore, it is intriguing to imagine an interaction between 
Par14 and AES. However, it seems that the peptide LPLTPLP is a target-unrelated peptide. 
Apart from the binding to HMG proteins reported by (Dintilhac and Bernués, 2002), the 
peptide LPLTPLP was also described as a binder for a variety of target proteins. For instance, 
it was selected in panning of a 7-mer library against the aminoacyle- tRNA site of 16 rRNA, 
but they have suggested that it binds RNA non-specifically (Li et al., 2009). Moreover, the 
same peptide was identified as a binder for human endothelium (Maruta et al., 2003). It was 
also enriched in a panning intended to search for cardiac targeting peptides when they panned 
the 7-mer Ph.D. library against WKY rat heart (Nicol et al., 2009). Recently, this peptide was 
proposed to be with unknown specificity (Vodnik et al., 2011).  
 
The peptide GKPMPPM was also enriched in the 3rd round of our Ph.D. library screening 
(tables 3.4; 3.6). This peptide (GKPMPPM) was also selected in other Ph.D. screens. It has 
been selected in panning against Polymer-Film Surfaces (Serizawa et al., 2007), and in a 
panning against the surface protein of the acute respiratory syndrome associated corona virus 
(Hüttinger, PhD thesis 2009). This peptide may be over-represented in the library, or probably 
a sticky peptide as proposed for proline rich regions (Williamson, 1994). 
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4.3. Peptides that bind Pin A from Cinarchaeum symbiosum  
The peptides that were enriched from the phage peptide library when it was screened against 
the PPIase PinA of C. symbiosum, HKRPRNN and HQSPWHH were used for NMR study in 
peptide-protein interaction to get more insight about its PPIase active site. In NMR 1H 15N 
HSQC titration, the peptide HQSPWHH binds PinA of C. symbiosum with low affinity (high 
micromolar / low millmolar range). Therefore, it could be used to demonstrate binding sites of 
C. symbiosum PinA whose NMR solution structure was recently solved (Jaremko et al., 
2011). It binds in a hydrophobic core formed from helix II, β sheet II and helix III. The amino 
acids residues that exhibited chemical shift changes in NMR titration namely are Phe31, 
Gly32, Gly42, Ser44, Gly53, Gly55, Gly57, Lys58, Val60, Phe83, Gly84, and Lys89. All 
these amino acid residues were around the postulated Proline binding cleft (figure 3.28. A). 
Furthermore, the peptide HQSPWHH was also used to demonstrate a flexible region in C. 
symbiosum PinA (from Ser44-Gly49). Since a glycine and two positively charged residues are 
conserved in all parvulins in this region, it was proposed that the flexibility of this region 
(figure 3.28.B,) might perform a general function in peptidyl prolyl cis/trans isomerization 
(Jaremko et al., 2011).  
 
We also found the peptide HAIYPRH in the 3rd round pool. This peptide was thought to be a 
binder for different targets until Brammer and others could demonstrate that it is a target-
unrelated peptide (Brammer et al., 2008). The phage clone expressing or “displaying” the 
peptide HAIYPRH has developed a mutation in the Shine-Dalgarno (SD) sequence for gIIp. 
This mutation enables the SD of gIIp to fit better in 16 S ribosome, and thereby it gives the 
phage the advantage of faster amplification than all of the phage of the library. Therefore, it 
amplifies without being selected in the panning (Brammer et al., 2008). 
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